You are here

Michael Knopp

  • Professor, Radiology
  • Professor, Veterinary Clinical Sciences
  • Professor, Computer Science & Engineering
  • Professor, Radiation Oncology
  • Professor, SBS-Biomedical Informatics
  • Room #430
    395 W 12th Ave
    Columbus, OH 43210
  • 614-293-9998

Honors

  • 2016

    Best Scientific Paper Presentation –Oncologic Imaging. .

  • 2016

    One of the Top 25 JMRI papers in the last 25 years. .

  • 2016

    Distinguished Investigator Award. .

  • 2016

    Second Place Poster - Educational Exhibits. .

  • 2015

    2014 Radiology Editor’s Recognition Award for reviewing with Distinction. .

  • 2015

    Outstanding Technology Team 2015 BizTech Awards. .

  • 2012

    Tech Oral Presentation Award: 1st Place: Quantitatively accurate dynamic SPECT/CT acquisition: Proof of concept in an antropomorphic phantom. .

  • 2012

    Innovation in Non-Profit Service Delivery. .

  • 2012

    Outstanding Technology Team - Runner Up. .

  • 2011

    Best Poster Award: Intravitreal Characteristics of I-124 Labelled Avastin and Lucentis with PET/CT. .

  • 2010

    Third Best Poster Award: Imaging of Retro-Orbital Vasculature and Central Retinal Vasculature with Ultra High Field 7T Magnetic Resonance Imaging Using Dedicated Eye Coil. .

  • 2010

    Certificate of Merit, Education Exhibit: The Human Brain in 2010 Pieces: An Interactive 3D Atlas of Structure, Vasculature, Tractography, and Function. .

  • 2009

    Certificate of Merit, Education Exhibit: Influences of the Parallel Imaging Technique SENSE on Ultra High Field Diffusion Tensor Imaging and Fibertracking at 7T. .

  • 2009

    Magna Cum Laude Award: A 3D Interactive Atlas of Cerebral Vasculature and Structure from 3T and 7T. .

  • 2009

    Magna Cum Laude Award, Education Exhibit: The Human Brain in 1,002 Pieces: A Comprehensive and Interactive 3D Atlas of Structure, Vasculature, and Connections from Multiple 3T and 7T Acquisitions. .

  • 2008

    Certificate of Merit, Educational Electronic Exhibit Awards: Imaging-pathology Correlation of 3T DCE-MRI without an Endorectal Coil used as a Presurgical Roadmap for Prostate Cancer Delineation. .

  • 2008

    Certificate of Merit, Education Exhibit: A 3D Interactive Atlas of Cerebral Arteries from 7T. .

  • 2008

    Kenneth R. Gottesfeld Award: Image segmentation for evaluating axillary lymph nodes. .

  • 2007

    Top 25 Innovators in Healthcare. .

  • 2007

    Contrast Media Research Award: Schelle MR- Kontrastmitteldynamik zur Charakterisierung von Tuumoren: Erfahrungen mit der funktionellen MR- Mammographie. .

  • 2006

    Doctor of Science, honoris causa. .

  • 2004

    John K. Lattimer Award. .

  • 2001

    Certificate of Merit, Scientific Exhibit Award: How to Implement an MRI Service for Functional Tumor Imaging?. .

  • 2001

    Magna Cum Laude Award, Scientific Exhibit: Monitoring of Breast Cancer Therapy with MRI: A Clinical Review of Indications, Findings, and Interpretation. .

  • 2000

    Poster Award: Dynamic MRI for monitoring of microcirculation in pleural mesothelioma: Clinical and histopathological correlation during therapeutic interventions. .

  • 2000

    Magna Cum Laude Poster Award: Phase II Studies of Gd-BOPTA (Multihance) for MR Angiography. .

  • 2000

    Certificate of Merit, Scientific Exhibit Award: Using Virtual Reality to Display MR Angiography: Tips, Tricks, and Useful Applications. .

  • 2000

    Certificate of Merit, Scientific Exhibit Award: Contrast Agents for MR Angiography: What Is or Will Be Available and Are There Differences?. .

  • 1999

    Poster Award: Is there a diagnostic benefit of gadobenate dimeglumine (Gd-BOPTA) for MR angiography?. .

  • 1999

    Poster Award: Multiphasic MR angiography of liver lesions with gadobenate dimeglumine (Gd-BOPTA). .

  • 1998

    Poster Award: Stellenwert der funktionellen Magnetresonanztomographie (MRT) für die Onkologische Diagnostik. .

  • 1997

    Poster Award: Dynamic gadolinium-enhanced MRI - a novel prognostic factor to predict lymphatic spread and tumor proliferation in cervical carcinoma. .

  • 1997

    Poster Award: Statistical methods for the assessment of radiological procedures: A paradigmatic application in functional MR-mammography. .

  • 1997

    EAR-ECR Fellowship Award: Which histiological and molecular biological factors influence the enhancements of Gadolinium contrast agents in tumors? In viva assessments of a pathophysiological Concept in breast tumors. .

  • 1995

    Poster Award: Proton-decoupled 31-P MR spectroscopy in the follow-up of neoadjuvant chemotherapy of breast cancer. .

  • 1995

    Poster Award: MR-mammographische Darstellung von Fibroadenomen. Eine radiologisch/histologische Korrelation. .

  • 1994

    Poster Award (1st Place): FDG-PET zum Therapiemonitoring von kleinzelligen Bronchialkarzinomen. .

  • 1993

    Poster of the Day: Magnetic Resonance Urography - An alternative technique to x-ray urography. .

  • 1992

    Poster Award: Neue Einsatzmöglichkeiten der Farbdopplersonographie: Das Mediastinum und seine Erkrankungen. .

  • 1992

    Poster Award: Fehlende Repopulation des Knochenmarks nach Strahlentherapie bei M. Hodgkin: MR-Tomographie und Quantifizierung durch "Chemical Shift Imaging. .

Books

2010

  • Nowinski WL, Chua BC, Qian G, Marchenko Y, Puspitasari F, Nowinska NG, Knopp MV. 2010. "The Human Brain in 1492 Pieces: Structure, Vasculature, and Tracts." New York: Thieme.

1999

  • 1999. "Registration of spatially consecutive 3d Mr data sets for an enhanced structural analysis of intrahepatic vessel trees." Elsevier Science Publishers B.V.Elsevier Science Publishing Co., Inc..

1996

  • 1996. "Cranial nerve imaging for radiosurgery at the base of the skull." S. Karger AGS. Karger AG.

1994

  • 1994. "Computer-assisted image analysis: A new diagnostic aid for quantitation of color Doppler information in breast tumors." S. Karger AGS. Karger AG.

Chapters

2016

  • Tweedle MF, Kumar K, Knopp MV. 2016. "X ray, MRI and Ultrasound Agents: Basic Principles." In Handbook of Small Animal Imaging: Preclinical Imaging, Therapy, and Applications, edited by Kagadis GC, Ford NL, Loudos GK, Karnabatidis D, 249 - 76. Boca Raton: CRC Press.

2011

  • FitzGerald TJ, Bishop-Jodoin M, Urie MM, Ulin K, Ibbott GS, Purdy JA, Saltz JH, Peters LJ, Cicchetti MG, Schnall M, Deasy J, Bosch WR, Knopp MV, Schartz LH, White KS, Hanusik R, Kessel SK, Morano K, Laurie F. 2011. "Quality Assurance of Clinical Trials in the Management of Cancer in the Head and Neck." In Head and Neck Cancer: Multimodality Management, edited by Jacques Bernier, 687 - 694. New York: Springer.

2010

  • Knopp MV. 2010. "Contrast Agents in Magnetic Resonance Imaging." In Imaging of the Cardiovascular System, edited by Vincent Ho and Gautham Reddy, 251 - 260. St. Louis: Elsevier Saunders.

2008

  • Knopp MV. 2008. "Advances in Contrast Agent Development for CT/MRI." In Handbook for Neuro-Oncology Neuroimaging, edited by Herbert B. Newton & Ferenc A. Jolesz, 316 - 321. New York: Elsevier.

2005

  • Knopp MV. 2005. "Dynamic Contrast-Enhanced MRI in Carcinoma of the Breast." In Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Oncology, edited by Jackson A, Buckley DL, Parker GJM, Berlin: Springer.

Journal Articles

2017

  • Wright CL, Maly JJ, Zhang J, Knopp MV, 2017, "Advancing Precision Nuclear Medicine and Molecular Imaging for Lymphoma." PET Clin 12, no. 1, 63 - 82.
  • Crandall JP, Tahari AK, Juergens RA, Brahmer JR, Rudin CM, Esposito G, Subramaniam DS, Knopp MV, Hall NC, Gajwani P, Leal JP, Lodge MA, O JH, Gabrielson EW, Shankar LK, Wahl RL, 2017, "A comparison of FLT to FDG PET/CT in the early assessment of chemotherapy response in stages IB-IIIA resectable NSCLC." EJNMMI Res 7, no. 1, 8 -

2016

  • Villalona-Calero MA, Lam E, Otterson GA, Zhao W, Timmons M, Subramaniam D, Hade EM, Gill GM, Coffey M, Selvaggi G, Bertino E, Chao B, Knopp MV, 2016, "Oncolytic reovirus in combination with chemotherapy in metastatic or recurrent non-small cell lung cancer patients with KRAS-activated tumors." Cancer 122, no. 6, 875 - 83.
  • Rezai AR, Sederberg PB, Bogner J, Nielson DM, Zhang J, Mysiw WJ, Knopp MV, Corrigan JD, 2016, "Improved Function After Deep Brain Stimulation for Chronic, Severe Traumatic Brain Injury." Neurosurgery 79, no. 2, 204 - 11.
  • Chafi H, Elias SN, Nguyen HT, Friel HT, Knopp MV, Guo B, Heymsfield SB, Jia G, 2016, "Effect of parallel radiofrequency transmission on arterial input function selection in dynamic contrast-enhanced 3 Tesla pelvic MRI." J Magn Reson Imaging 43, no. 1, 229 - 35.
  • Press OW, Li H, Schöder H, Straus DJ, Moskowitz CH, LeBlanc M, Rimsza LM, Bartlett NL, Evens AM, Mittra ES, LaCasce AS, Sweetenham JW, Barr PM, Fanale MA, Knopp MV, Noy A, Hsi ED, Cook JR, Lechowicz MJ, Gascoyne RD, Leonard JP, Kahl BS, Cheson BD, Fisher RI, Friedberg JW, 2016, "US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emmission Tomography Imaging: Southwest Oncology Group S0816." J Clin Oncol 34, no. 17, 2020 - 7.
  • Clark DJ, Smith AK, Dortch RD, Knopp MV, Smith SA, 2016, "Investigating hydroxyl chemical exchange using a variable saturation power chemical exchange saturation transfer (vCEST) method at 3 T." Magn Reson Med 76, no. 3, 826 - 37.
  • Schmalbrock P, Prakash RS, Schirda B, Janssen A, Yang GK, Russell M, Knopp MV, Boster A, Nicholas JA, Racke M, Pitt D, 2016, "Basal Ganglia Iron in Patients with Multiple Sclerosis Measured with 7T Quantitative Susceptibility Mapping Correlates with Inhibitory Control." Am J Neuroradiol 37, no. 3, 439 - 46.
  • Langsteger W, Rezaee A, Loidl W, Geinitz HS, Fitz F, Steinmair M, Broinger G, Pallwien-Prettner L, Beheshti M, Imamovic L, Beheshti M, Rendl G, Hackl D, Tsybrovsky O, Steinmair M, Emmanuel K, Moinfar F, Pirich C, Langsteger W, Bytyqi A, Karanikas G, Mayerhöfer M, Koperek O, Niederle B, Hartenbach M, Beyer T, Herrmann K, Czernin J, Rausch I, Rust P, DiFranco MD, Lassen M, Stadlbauer A, Mayerhöfer ME, Hartenbach M, Hacker M, Beyer T, Binzel K, Magnussen R, Wei W, Knopp MU, Flanigan DC, Kaeding C, Knopp MV, et al, 2016, "32nd International Austrian Winter Symposium : Zell am See, the Netherlands. 20-23 January 2016." EJNMMI Res 6, no. Suppl 1, 32 -
  • FitzGerald TJ, Bishop-Jodoin M, Followill DS, Galvin J, Knopp MV, Michalski JM, Rosen MA, Bradley JD, Shankar LK, Laurie F, Cicchetti MG, Moni J, Coleman CN, Deye JA, Capala J, Vikram B, 2016, "Imaging and Data Acquisition in Clinical Trials for Radiation Therapy." Int J Radiat Oncol Biol Phys 94, no. 2, 404 - 11.
  • Wright CL, Zhang J, Binzel K, Wuthrick EJ, Knopp MV, 2016, "90Y Digital PET/CT Imaging Following Radioembolization." Clin Nucl Med 41, no. 12, 975 - 76.

2015

  • Shah ZK, Elias SN, Abaza R, Zynger DL, DeRenne LA, Knopp MV, Guo B, Schurr R, Heymsfield SB, Jia G, 2015, "Performance Comparison of 1.5-T Endorectal Coil MRI with 3.0-T Nonendorectal Coil MRI in Patients with Prostate Cancer." Acad Radiol 22, no. 4, 467 - 74.
  • Nguyen HT, Jia G, Shah ZK, Pohar K, Mortazavi A, Zynger DL, Wei L, Yang X, Clark D, Knopp MV, 2015, "Prediction of chemotherapeutic response in bladder cancer using K-means clustering of dynamic contrast-enhanced (DCE)-MRI pharmacokinetic parameters." J Magn Reson Imaging 41, no. 5, 1374 - 82.
  • Grundmann IN, Drost WT, Zekas LJ, Belknap JK, Garabed RB, Weisbrode SE, Parks AH, Knopp MV, Maierl J, 2015, "Quantitative assessment of the equine hoof using digital radiography and magnetic resonance imaging." Equine Vet J 47, no. 5, 542 - 7.
  • Wright CL, Zhang J, Tweedle MF, Knopp MV, Hall NC, 2015, "Theranostic Imaging of Yttrium-90." Biomed Res Int 2015, 481279 -
  • Ammirati M, Lamki T, Chitnis G, Yang X, Russell D, Coble D, Kaur B, Knopp MV, Moore S, Ziaie B, 2015, "In vivo brain electrophoresis – a novel method for chemotherapy of CNS diseases." Expert Opin Drug Deliv 12, no. 5, 727 - 34.
  • Wu C, Mikhail S, Wei L, Timmers C, Tahiri S, Neal A, Walker J, El-Dika S, Blazer M, Rock J, Clark DJ, Yang X, Chen JL, Liu J, Knopp MV, Bekaii-Saab T, 2015, "A phase II and pharmacodynamic study of sunitinib in relapsed/refractory oesophageal and gastro-oesophageal cancers." Br J Cancer 113, no. 2, 220 - 5.
  • Ellingson BM, Bendszus M, Boxerman J, Barboriak D, Erickson BJ, Smits M, Nelson SJ, Gerstner E, Alexander B, Goldmacher G, Wick W, Vogelbaum M, Weller M, Galanis E, Kalpathy-Cramer J, Shankar L, Jacobs P, Pope WB, Yang D, Chung C, Knopp MV, Cha S, van den Bent MJ, Chang S, Al Yung WK, Cloughesy TF, Wen PY, Gilbert MR, 2015, "Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials." Neuro Oncol 17, no. 9, 1188 - 98.

2014

  • Mrózek E, Layman R, Ramaswamy B, Lustberg M, Vecchione A, Knopp MV, Shapiro CL, 2014, "Phase II Trial of Neoadjuvant Weekly Nanoparticle Albumin-Bound Paclitaxel, Carboplatin, and Biweekly Bevacizumab Therapy in Women With Clinical Stage II or III HER2-Negative Breast Cancer." Clin Breast Cancer 14, no. 4, 228 - 34.
  • Campbell AB, Quatman CE, Schmitt LC, Knopp MV, Flanigan DC, 2014, "Is Magnetic Resonance Imaging Assessment of the Size of Articular Cartilage Defects Accurate?." J Knee Surg 27, no. 1, 67 - 75.
  • Wei W, Jia G, Flanigan D, Zhou J, Knopp MV, 2014, "Chemical exchange saturation transfer MR imaging of articular cartilage glycosaminoglycans at 3 T: Accuracy of B0 field inhomogeneity corrections with gradient echo method." Magn Reson Imaging 32, no. 1, 41 - 77.
  • Nguyen HT, Pohar KS, Jia G, Shah ZK, Mortazavi A, Zynger DL, Wei L, Clark D, Yang X, Knopp MV, 2014, "Improving Bladder Cancer Imaging Using 3-T Functional Dynamic Contrast-Enhanced Magnetic Resonance Imaging." Invest Radiol 49, no. 6, 390 - 5.
  • Huang Z, Yuh KA, Lo SS, Grecula JC, Sammet S, Sammet CL, Jia G, Knopp MV, Wu Q, Beauchamp NJ 3rd, Yuh WT, Wang R, Mayr NA, 2014, "Improving Bladder Cancer Imaging Using 3-T Functional Dynamic Contrast-Enhanced Magnetic Resonance Imaging." J Magn Reson Imaging 32, no. 10, 1198 - 205.
  • Mrozek E, Layman R, Ramaswamy B, Lustberg M, VcchioneA, Knopp MV, Shapiro CL, 2014, "Phase II Trial of Neoadjuvant Weekly Nanoparticle Albumin-Bound Paclitaxel, Carboplatin, and Biweekly Bevacizumab Therapy in Women With Clinical Stage II or III HER2-Negative Breast Cancer." Clin Breast Cancer 14, no. 4, 228 - 34.

2013

  • Stamm AC, Wright CL, Knopp MV, Schmalbrock P, Heverhagen JT, 2013, "Phase contrast and time-of-flight magnetic resonance angiography of the intracerebral arteries at 1.5, 3 and 7T." Magn Reson Imaging 31, no. 4, 545 - 9.
  • Campbell AB, Knopp MV, Kolovich G, Wei W, Jia G, Siston RA, Flanigan DC, 2013, "Preoperative MRI Underestimates Articular Cartilage Defect Size Compared to Arthroscopy." Am J Sports Med 41, no. 3, 590 - 5.
  • Povoski SP, Hall NC, Murrey DA Jr, Chow AZ, Gaglani JR, Bahnson EE, Mojzisik CM, Kuhrt MP, Hitchcock CL, Knopp MV, Martin EW Jr, 2013, "Multimodal Imaging and Detection Strategy with 124 I-Labeled Chimeric Monoclonoal Antibody cG250 for Accurate Localization and Confirmation of Extent of Disease During Laparoscopic and Open Surgical Resection of Clear Cell Renal Cell Carcinoma." Surg Innov 20, no. 1, 59 - 69.
  • Nowinski WL, Puspitasari F, Volkau I, Orrison WW, Knopp MV, 2013, "Quantification of the Human Cerebrovasculature – a 7 Tesla and 320-Row CT In Vivo Study." J Comput Assist Tomogr 37, no. 1, 117 - 22.
  • Christoforidis JB, Wassenaar PA, Christoforidis GA, Ho VY, Knopp MV, Schmalbrock P, 2013, "Retrobulbar vasculature using 7-T magnetic resonance imaging with dedicated eye surface coil." Graefes Arch Clin Exp Ophthalmol 251, no. 1, 271 - 7.
  • Christoforidis JB, Williams MM, Epitropoulos FM, Knopp MV, 2013, "Subconjunctival bleb that forms at the injection site after intravitreal injection is drug, not vitreous." Clin Experiment Ophthalmol 41, no. 6, 614 - 5.
  • Fitzgerald TJ, Bishop-Jodoin M, Bosch WR, Curran WJ, Followill DS, Galvin JM, Hanusik R, King SR, Knopp MV, Laurie F, O'Meara E, Michalski JM, Saltz JH, Schnall MD, Schwartz L, Ulin K, Xiao Y, Urie M, 2013, "Future vision for the quality assurance of oncology clinical trials." Front Oncol 3, no. 41, 1 - 10.
  • Hall NC, Povoski SP, Zhang J, Knopp MV, Martin EW Jr, 2013, "Use of intraoperative nuclear medicine imaging technology: strategy for improved patient management." Expert Rev Med Devices 10, no. 2, 149 - 52.
  • Nowinski WL, Puspitasaari F, Volkau I, Marchenko Y, Knopp MV, 2013, "Comparison of Magnetic Resonance Angiography Scans on 1.5, 3, and 7 Tesla Units: A Quantitative Study of Three-Dimensional Cerebrovasculature." J Neuroimaging 23, no. 1, 86 - 95.
  • Sammet CL, Yang X, Wassenaar PA, Bourekas EC, Yuh BA, Shellock F, Sammet S, Knopp MV, 2013, "RF-related heating assessment of extracranial neurosurgical implants at 7T." Magn Reson Imaging 31, no. 6, 1029 - 34.
  • Christoforidis JB, Williams MM, Wang J, Jiang A, Pratt C, Abdel-Rasoul M, Hinkle GH, Knopp MV, 2013, "Anatomic and Pharmacokinetic Properties of Intravitreal Bevacizumab and Ranibizumab After Vitrectomy and Lensectomy." Retina 33, no. 5, 946 - 52.

2012

  • Christoforidis JB, Williams MM, Kothandaraman S, Kumar K, Epitropoulos FJ, Knopp MV, 2012, "Pharmacokinetic Properties of Intravitreal I-124 Aflibercept in a Rabbit Model Using PET/CT." Curr Eye Res 37, no. 12, 1171 - 4.
  • Bluestein KT, Pitt D, Knopp MV, Schmalbrock P, 2012, "T1 and proton density at 7T in patients with multiple sclerosis: an initial study." Magn Reson Imaging 30, no. 1, 19 - 25.
  • Bluestein KT, Pitt D, Sammet S, Zachariah CR, Nagaraj U, Knopp MV, Schmalbrock P, 2012, "Detecting cortical lesions in multiple sclerosis at 7T using white matter signal attenuation." Magn Reson Imaging 30, no. 7, 907 - 15.
  • Nowinski WL, Puspitasaari F, Volkau I, Marchenko Y, Knopp MV, 2012, "Comparison of Magnetic Resonance Angiography Scans on 1.5, 3, and 7 Tesla Units: A Quantitative Study of Three-Dimensional Cerebrovasculature." J Neuroimaging
  • Harris JD, Brophy RH, Jia G, Price B, Knopp MV, Siston RA, Flanigan DC, 2012, "Sensitivity of Magnetic Resonance Imaging for Detection of Patellofemoral Articular Cartilage Defects." Arthroscopy 28, no. 11, 1728 - 37.
  • Kocak E, Carruthers KH, Knopp MV, Carkaci S, Martin EW Jr, Stephen PP, 2012, "Image-guided technologies to facilitate the dissection of microsurgical autologous tissue-free flaps." Expert Rev Med Devices 9, no. 6, 547 - 9.
  • Mayr NA, Huang Z, Wang JZ, Lo SS, Fan JM, Grecula JC, Sammet S, Sammet CL, Jia G, Zhang J, Knopp MV, Yuh WT, 2012, "Characterizing Tumor Heterogeneity with Functional Imaging and Quantifying High-Risk Tumor Volume for Early Prediction of Treatment Outcome: Cervical Cancer as a Model." Int J Radiat Oncol Biol Phys
  • Martin LK, Jia G, Wei L, Yang X, Grecula J, Otterson G, Harper E, Kefauver C, Shah ZK, Zhou B, Yen Y, Bloomston M, Knopp MV, Espinoza-Delgado I, Grever M, Bekaii-Saab T, 2012, "A dose escalation and pharmacodynamic study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine) and radiation in patients with locally advanced pancreas cancer." Int J Radiat Oncol 84, no. 4, e475 - 81.
  • Martin-Vaquero P, da Costa RC, Echandi RL, Sammet CL, Knopp MV, Sammet S, 2012, "Magnetic Resonance Spectroscopy of the Canine Brain at 3.0T and 7.0T." Res Vet Sci 93, no. 1, 427 - 9.
  • Erdal BS, Crouser ED, Yildiz V, King MA, Patterson AT, Knopp MV, Clymer BD, 2012, "Quantitative Computerized Two-Point Correlation Analysis of Lung CT Scans Correlates with Pulmonary Function in Pulmonary Sarcoidosis." Chest 142, no. 6, 1589 - 97.
  • Mayr NA, Huang Z, Wang JZ, Lo SS, Fan JM, Grecula JC, Sammet S, Sammet CL, Jia G, Zhang J, Knopp MV, Yuh WT, 2012, "Characterizing Tumor Heterogeneity with Functional Imaging and Quantifying High-Risk Tumor Volume for Early Prediction of Treatment Outcome: Cervical Cancer as a Model." Int J Radiat Oncol Biol Phys 83, no. 3, 972 - 9.
  • Yang X, Mrozek E, Lustberg M, Jia G, Sammet S, Sammet C, Shapiro C, Knopp MV, 2012, "Microcirculatory Fraction (MCFi) as a Potential Imaging Marker for Tumor." Magn Reson Imaging 30, no. 8, 1059 - 67.

2011

  • Choi S, Cunningham DT, Aguila F, Corrigan JD, Bogner J, Mysiw WJ, Knopp MV, Schmalbrock P, 2011, "DTI at 7T and 3T: Systematic Comparison of SNR and its Influence on Quantitative Metrics." Magn Reson Imaging 29, no. 6, 739 - 51.
  • Christoforidis JB, Carlton MM, Knopp MV, Hinkle GH, 2011, "PET/CT imaging of I-124 radiolabeled bevacizumab and ranibizumab after intravitreal injection in a rabbit model." Invest Ophthalmol Vis Sci 52, no. 8, 5899 - 903.
  • Menendez MI, Clark DJ, Carlton M, Flanigan DC, Jia G, Sammet S, Weisbrode SE, Knopp MV, Bertone AL, 2011, "Direct delayed human adenoviral BMP-2 or BMP-6 gene therapy for bone and cartilage regeneration in a pony osteochondral model." Osteoarthritis Cartilage 19, no. 8, 1066 - 75.
  • Jia G, Abaza R, Williams JD, Zynger DL, Zhou J, Shah ZK, Patel M, Sammet S, Wei L, Bahnson RR, Knopp MV, 2011, "Amide Proton Transfer MR Imaging of Prostate Cancer: A Preliminary Study." J Magn Reson Imaging 33, no. 3, 647 - 54.
  • Poon DP, Langkals J, Giesel FL, Knopp MV, von Tengg-Kobligk H,, 2011, "Internet-Based Videoconferencing and Data Collection for the Imaging Community." J Comput Assist Tomogr 35, no. 6, 753 - 61.
  • Martin-Vaquero P, da Costa RC, Echandi RL, Tosti CL, Knopp MV, Sammet S, 2011, "Magnetic Resonance Imaging of the Canine Brain at 3T and 7T." Vet Radiol Ultrasound 52, no. 1, 25 - 32.
  • Jia G, Takayama Y, Flanigan DC, Kaeding CC, Zhou J, Chaudhari A, Clark D, Sammet S, Liang J, Choi S, Knopp MV, 2011, "Quantitative Assessment of Mobile Protein Levels in Human Knee Synovial Fluid: Feasibility of Chemical Exchange Saturation Transfer (proteinCEST) MRI of Osteoarthritis." Magn Reson Imaging 29, no. 3, 335 - 41.
  • Christoforidis GA, Rink C, Kontzialis MS, Mohammad Y, Koch RM, Abduljalil AM, Bergdall VK, Roy S, Khanna S, Slivka AP, Knopp MV, Sen CK, 2011, "An Endovascular Canine Middle Cerebral Artery Occlusion Model for the Study of Leptomeningeal Collateral Recruitment." Invest Radiol 46, no. 1, 34 - 40.
  • Nowinski WL, Chua BC, Marchenko Y, Puspitsari F, Volkau I, Knopp MV, 2011, "Three-dimensional Reference and Stereotactic Atlas of Human Cerebrovasculature from 7 Tesla." Neuroimage 55, no. 3, 986 - 98.
  • Yang X, Knopp MV, 2011, "Quantifying Tumor Vascular Heterogeneity with Dynamic Contrast Enhanced Magnetic Resonance Imaging: A Review." J Biomed Biotechnol 2011, 732848 -
  • Martin-Vaquero P, da Costa RC, Echandi RL, Tosti CL, Knopp MV, Sammet S, 2011, "Time-of-flight magnetic resonance angiography of the canine braine at 3.0 Tesla and 7.0 Tesla." Am J Vet Res 72, no. 3, 350 - 6.
  • Povoski SP, Hall NC, Murrey DA Jr, Chow AZ, Gaglani JR, Bahnson EE, Mojzisik CM, Kuhrt MP, Hitchcock CL, Knopp MV, Martin EW Jr, 2011, "Multimodal imaging and detection approach to 18F-FDG-directed surgery for patients with known or suspected malignancies: a comprehensive description of the specific methodology utilized in a single-institution cumulative retrospective experience." World J Surg Oncol 9, 152 -
  • Bluestein KT, Pitt D, Knopp MV, Schmalbrock P, 2011, "T1 and Proton Density at 7T in Patients with Multiple Sclerosis: An Initial Study." Magn Reson Imaging
  • Yuh WTC, Christoforidis GA, Mayr NA, Sammet CT, Nowinski WL, Knopp MV, Sammet S, 2011, "Ultrahigh field clinical MR imaging: Challenge and excitement." US Radiology 3, no. 1, 16 - 22.

2010

  • Janoos F, Machiraju R, Sammet S, Knopp MV, Mórocz IA, 2010, "Unsupervised Learning of Brain States from fMRI Data." Med Image Comput Comput Assist Interv 13, no. Pt 2, 201 - 8.
  • Liang J, Sammet S, Yang X, Jia G, Takayama Y, Knopp MV, 2010, "Intraindividual In Vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast-enhanced MR imaging." Invest Radiol 45, no. 5, 233 - 44.
  • Lam ET, Ringel MD, Kloos KT, Prior T, Knopp MV, Liang J, Sammet S, Hall NC, Wakely Jr PE, Vasko VV, Saji M, Snyder P, Wei L, Arbogast D, Collamore M, Wright JJ, Moley J, Villalona-Calero MA, Shah MH, 2010, "Phase II Clinical Trial of the Multi-Kinase Inhibitor, Sorafenib, in Metastatic Medullary Thyroid Cancer." J Clin Oncol 28, no. 14, 2323 - 30.
  • Pitt D, Boster A, Pei W, Wohleb E, Jasne A, Zachariah CR, Rammohan K, Knopp MV, Schmalbrock P, 2010, "Imaging Cortical Lesions in Multiple Sclerosis With Ultra–High-Field Magnetic Resonance Imaging." Arch Neurol 67, no. 7, 812 - 18.
  • Zou P, Povoski SP, Hall NC, Carlton MM, Hinkle GH, Xu RX, Mojzisik CM, Johnson MA, Knopp MV, Martin EW Jr, Sun D, 2010, "124I-HuCC49deltaCH2 for TAG-72 antigen-directed positron emission tomography (PET) imaging of LS174T colon adenocarcinoma tumor implants in xenograft mice: preliminary results." World J Surg Onc 8, 65 -
  • Mayr NA, Wang JZ, Zhang D, Grecula JC, Lo SS, Jaroura D, Montebello J, Zhang H, Li K, Lu L, Huang Z, Fowler JM, Wu DH, Knopp MV, Yuh WT, 2010, "Longitudinal Changes in Tumor Perfusion Pattern during the Radiation Therapy Course and its Clinical Impact in Cervical Cancer." Int J Radiat Oncol Biol Phys 77, no. 2, 502 - 8.
  • Hall NC, Povoski SP, Murrey DA, Martin EW Jr, Knopp MV, 2010, "Ex vivo specimen FDG PET/CT imaging for oncology." Radiology 255, no. 2, 663 - 4; author reply.
  • Steinberg J, Jia G, Sammet S, Zhang J, Hall NC, Knopp MV, 2010, "Three-region MRI-based whole-body attenuation correction for automated PET reconstruction." Nucl Med Biol 37, no. 2, 227 - 35.
  • Sammet S, Koch RM, Aguila F, Knopp MV, 2010, "Residual magnetism in an MR Suite after Field-rampdown – What are the Issues and Experiences?." J Magn Reson Imaging 31, no. 5, 1272 - 6.
  • Yang X, Sammet S, Schmalbrock P, Knopp MV, 2010, "Postprocessing Correction for Distortions in T2* Decay Caused by Quadratic Cross-Slice B0 Inhomogeneity." Magn Reson Med 63, no. 5, 1258 - 68.
  • Nowinski WL, Choon Chua B, Volkau I, Puspitasari F, Marchenko Y, Runge VM, Knopp MV, 2010, "Simulation and assessment of cerebrovascular damage in deep brain stimulation using a stereotactic atlas of vasculature and structure derived from multiple 3T and 7T scans." J Neurosurg 113, no. 6, 1234 - 41.

2009

  • Nijdam AJ, Nicholson III TR, Shapiro JP, Smith BR, Heverhagen JT, Schmalbrock P, Knopp MV, Kebbel A, Wang D, Lee SC, 2009, "Nanoparticulate Iron Oxide Contrast Agents for Untargeted and Targeted Cardiovascular Magnetic Resonance Imaging." Curr Nanosci 5, no. 1, 88 - 102.
  • Giesel FL, Mehndiratta A, Locklin J, McAuliffe MJ, White S, Choyke PL, Knopp MV, Wood BJ, Haberkorn U, von Tengg-Kobligk H, 2009, "Image fusion using CT, MRI and PET for treatment planning, navigation and follow up in percutaneous RFA." Exp Oncol 31, no. 2, 106 - 14.
  • Janoos F, Nouanesengsy B, Machiraju R, Shen HW, Sammet S, Knopp MV, Mórocz IÃ�, 2009, "Visual Analysis of Brain Activity from fMRI Data." Computer Graphics Forum 28, no. 3, 903 - 10.
  • Kloos RT, Ringel MD, Knopp MV, Hall NC, King M, Stevens R, Liang J, Wakely PE Jr, Vasko VV, Saji M, Rittenberry J, Wei L, Arbogast D, Collamore M, Wright JJ, Grever M, Shah MH, 2009, "Phase II Trial of Sorafenib in Metastatic Thyroid Cancer." J Clin Oncol 27, no. 10, 1675 - 84.
  • Povoski SP, Neff RL, Mojzisik CM, O'Malley DM, Hinkle GH, Hall NC, Murrey DA Jr, Knopp MV, Martin EW Jr, 2009, "A Comprehensive Overview of Radioguided Surgery Using Gamma Detection Probe Technology." World J Surg Oncol 7, no. 1, 11. Review -
  • Murrey DA Jr, Bahnson EE, Hall NC, Povoski SP, Mojzisik CM, Young DC, Sharif S, Johnson MA, Abdel-Misih S, Martin EW Jr, Knopp MV, 2009, "Perioperative (18)F-fluorodeoxyglucose-guided using the becquerel as a quantitative measure for optimizing surgical resection in patients with advanced malignancy." Am J Surg 198, no. 6, 834 - 40.
  • Heverhagen JT, Wright CL, Schmalbrock P, Knopp MV, 2009, "Dose comparison of single versus double dose in contrast-enhanced magnetic resonance angiography of the renal arteries: intra-individual cross-over blinded trial using Gd-DTPA." Eur Radiol 19, no. 1, 67 - 72.
  • Hall NC, Zhang J, Povoski SP, Martin EW Jr, Knopp MV, 2009, "New developments in imaging and functional biomarker technology for the assessment and management of cancer patients." Expert Rev Med Devices 6, no. 4, 347 - 51.
  • Burdette D, Albani D, Chesi E, Clinthorne NH, Cochran E, Honscheid K, Huh SS, Kagan H, Knopp MV, Lacasta C, Mikuz M, Schmalbrock P, Studen A, Weilhammer P, 2009, "A device to measure the effects of strong magnetic fields on the image resolution of PET scanners." Nucl Instrum Meth A 609, no. 2-3, 263 - 71.
  • Richdale K, Wassenaar P, Bluestein KT, Abduljalil A, Christoforidis JA, Lanz T, Knopp MV, Schmalbrock P, 2009, "7 Tesla MR Imaging of the Human Eye in vivo." J Magn Reson Imaging 30, no. 5, 924 - 32.
  • Christoforidis GA, Yang M, Kontzialis MS, Larson DG, Abduljalil A, Basso M, Yang W, Ray-Chaudhury A, Heverhagen JT, Knopp MV, Barth RF, 2009, "High resolution ultra-high field magentic resonance imaging of glioma microvascularity and hypoxia using ultra-small particles of iron oxide." Invest Radiol 44, no. 7, 375 - 83.
  • Yuh WT, Mayr NA, Jarjoura D, Wu D, Grecula JC, Lo SS, Edwards SM, Magnotta VA, Sammet S, Zhang H, Montebello JF, Fowler J, Knopp MV, Wang JZ, 2009, "Predicting Control of Primary Tumor and Survival by DCE MRI During Early Therapy in Cervical Cancer." Invest Radiol 44, no. 6, 343 - 50.
  • Mehndiratta A, Knopp MV, Zechmann CM, Owsijewitsch M, von Tengg-Kobligk H, Zamecnik P, Kauczor HU, Choyke PL, Gielsel FL, 2009, "Comparison of diagnostic quality and accuracy in color-coded versus gray-scale DCE-MR imaging display." Int J CARS 4, no. 5, 457 - 62.
  • Bahnson EE, Murrey DA, Mojzisik CM, Hall NC, Martinez-Suarez HJ, Knopp MV, Martin EW, Povoski SP, Bahnson RR, 2009, "PET/CT imaging of clear cell renal cell carcinoma with I labeled chimeric antibody.." Ther Adv Urol 1, no. 2, 67 - 70.

2008

  • Rink C, Christoforidis G, Abduljalil A, Kontzialis M, Bergdall V, Roy S, Khanna S, Slivka A, Knopp MV, Sen CK, 2008, "Minimally invasive neuroradiologic model of preclinical transient middle cerebral artery occlusion in canines." Proc Natl Acad Sci USA 105, no. 37, 14100 - 5.
  • Giesel FL, Choyke PL, Mehndiratta A, Zechmann CM, von Tengg-Kobligk H, Kayser K, Bischoff H, Hintze C, Delorme S, Weber MA, Essig M, Kauczor HU, Knopp MV, 2008, "Pharmacokinetic Analysis of Malignant Pleural Mesothelioma - Initial Results of Tumor Microcirculation and its Correlation to Microvessel Density (CD-34)." Acad Radiol 15, no. 5, 563 - 70.
  • Yang X, Liang J, Heverhagen JT, Jia G, Schmalbrock P, Sammet S, Koch R, Knopp MV, 2008, "Improving the Pharmacokinetic Parameter Measurement in DCE-MRI by Use of the Arterial Input Function: Theory and Clinical Application." Magn Reson Med 59, no. 6, 1448 - 56.
  • Jia G, O'Dell C, Heverhagen JT, Yang X, Liang J, Jacko RV, Sammet S, Pellas T, Cole P, Knopp MV, 2008, "Colorectal Liver Metastases: Contrast Agent Diffusion Coefficient for Quantification of Contrast Enhancement Heterogeneity at MR Imaging." Radiology 248, no. 3, 901 - 9.
  • Irfanoglu MO, Machiraju R, Sammet S, Pierpaoli C, Knopp MV, 2008, "Automatic Deformable Diffusion Tensor Registration for Fiber Population Analysis." Medical Image Computing and Computer Assisted Intervention 11, no. Pt 2, 1014 - 22.
  • Chun H, Clymer B, Sammet S, Koch RM, Stevens R, Knopp MV, 2008, "Improvement in the reproducibility of region of interest using an auditory feedback loop: A pilot assessment using dynamic contrast-enhanced (DCE) breast MR images." J Magn Reson Imaging 27, no. 1, 27 - 33.
  • Hall NC, Povoski SP, Murrey DA, Knopp MV, Martin EW, 2008, "Bringing Advanced Medical Imaging into the Operative Arena Could Revolutionize the Surgical Care of Cancer Patients." Expert Review of Medical Devices 5, no. 6, 663 - 7.
  • Cao X, Bloomston M, Zhang T, Frankel WL, Jia G, Wang B, Hall NC, Koch RM, Cheng H, Knopp MV, Sun D, 2008, "Synergistic Antipancreatic Tumor Effect by Simultaneously Targeting Hypoxic Cancer Cells With HSP90 Inhibitor and Glycolysis Inhibitor." Clin Cancer Res 14, no. 6, 1831 - 9.
  • Kale MC, Clymer BD, Koch RM, Heverhagen JT, Sammet S, Stevens R, Knopp MV, 2008, "Multispectral Co-occurrence with Three Random Variables in Dynamic Contrast Enhanced Magnetic Resonance Imaging of Breast Cancer." IEEE Trans Med Imaging 27, no. 10, 1425 - 31.
  • Povoski SP, Sarikaya I, White WC, Marsh SG, Hall NC, Hinkle GH, Martin EW Jr, Knopp MV, 2008, "Comprehensive Evaluation of Occupational Radiation Exposure to Intraoperative and Perioperative Personnel from 18F-FDG Radioguided Surgical Procedures." Eur J Nucl Med Mol Imaging 35, no. 11, 2026 - 34.
  • Heverhagen JT, Bourekas E, Sammet S, Knopp MV, Schmalbrock P, 2008, "Time-of-Flight Magnetic Resonance Angiography at 7 Tesla." Invest Radiol 43, no. 8, 568 - 73.
  • Cao X, Jia G, Zhang T, Yang M, Wang B, Wassenaar PA, Cheng H, Knopp MV, Sun D, 2008, "Non-invasive MRI tumor imaging and synergistic anticancer effect of HSP90 inhibitor and glycolysis inhibitor in RIP1-Tag2 transgenic pancreatic tumor model." Cancer Chemother Pharmacol 62, no. 6, 985 - 94.

2007

  • Hall NC, Povoski SP, Murrey DA, Knopp MV, Martin EW Jr, 2007, "Combined approach of perioperative 18F-FDG PET/CT imaging and intraoperative 18F-FDG handheld gamma probe detection for tumor localization and verification of complete tumor resection in breast cancer." World J Surg Oncol 5, 143 -
  • Evans KD, Weiss B, Knopp MV, 2007, "High-Intensity Focused Ultrasound (HIFU) for Specific Therapeutic Treatments: A Literature Review." J Diagnostic Medical Sonography 23, no. 6, 319 - 27.
  • Woods BJ, Clymer BD, Heverhagen JT, Knopp MV, Saltz J, Kurc T, 2007, "Parallel four-dimensional Haralick texture analysis for disk-resident image datasets." Concurrency Computat Pract Exper 19, no. 1, 65 - 87.
  • Evans KD, Li X, Robertson S, Knopp MV, 2007, "Sonographic Assessment of Axillary Lymph Nodes After a Mammographically Recommended Breast Sonogram for Women 55 Years and Older: A Feasibility Study." J Diagnostic Medical Sonography 23, no. 5, 263 - 71.
  • Heverhagen JT, Jourdan C, Knopp MV, 2007, "Response." J Magn Reson Imaging 26, no. 4, 1174 -
  • Woods BJ, Clymer BD, Kurc T, Heverhagen JT, Stevens R, Orsdemir A, Bulan O, Knopp MV, 2007, "Malignant-lesion segmentation using 4D co-occurrence texture analysis applied to dynamic contrast-enhanced magnetic resonance breast image data." J Magn Reson Imaging 25, no. 3, 495 - 501.
  • Smith BR, Heverhagen J, Knopp M, Schmalbrock P, Shapiro J, Shiomi M, Moldovan NI, Ferrari M, Lee SC, 2007, "Localization to atherosclerotic plaque and biodistribution of biochemically derivatized superparamagnetic iron oxide nanoparticles (SPIONs) contrast particles for magnetic resonance imaging (MRI).." Biomed Microdevices 9, no. 5, 719 - 27.
  • Sarikaya I, Povoski SP, Al-Saif OH, Kocak E, Bloomston M, Marsh S, Cao Z, Murrey DA, Zhang J, Hall NC, Knopp MV, Martin EW Jr, 2007, "Combined use of preoperative 18F FDG-PET imaging and intraoperative gamma probe detection for accurate assessment of tumor recurrence in patients with colorectal cancer." World J Surg Oncol 5, 80 -
  • Kuhn MJ, Picozzi P, Maldjian JA, Schmalfuss IM, Maravilla KR, Bowen BC, Wippold FJ 2nd, Runge VM, Knopp MV, Wolansky LJ, Gustafsson L, Essig M, Anzalone N, 2007, "Evaluation of intraaxial enhancing brain tumors on magnetic resonance imaging: intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for visualization and assessment, and implications for surgical intervention." J Neurosurg 106, no. 4, 557 - 66.
  • Sarikaya I, Bloomston M, Povoski SP, Zhang J, Hall NC, Knopp MV, Martin EW Jr, 2007, "FDG-PET Scan in Patients with Clinically and/or Radiologically Suspicious Colorectal Cancer Recurrence but Normal CEA." World J Surg Oncol 5, 64 -
  • Jourdan C, Heverhagen JT, Knopp MV, 2007, "Dose comparison of single- vs. double-dose in contrast-enhanced magnetic resonance angiography of the carotid arteries: Intraindividual cross-over blinded trial using Gd-DTPA.." J Magn Reson Imaging 25, no. 3, 557 - 63.

2006

  • Mosaliganti K, Jia G, Heverhagen J, Machiraju R, Saltz J, Knopp M, 2006, "Preventing signal degradation during elastic matching of noisy DCE-MR eye images." Med Image Comput Comput Assist Interv Int 9, no. Pt 1, 832 - 9.
  • Essig M, Weber MA, von Tengg-Kobligk H, Knopp MV, Yuh WT, Giesel FL, 2006, "Contrast-enhanced magnetic resonance imaging of central nervous system tumors: agents, mechanisms, and applications." Top Magn Reson Imaging 17, no. 2, 89 - 106. Review.
  • Kobayashi H, Kawamoto S, Bernardo M, Brechbiel MW, Knopp MV, Choyke PL, 2006, "Delivery of gadolinium-labeled nanoparticles to the sentinel lymph node: comparison of the sentinel node visualization and estimations of intra-nodal gadolinium concentration by the magnetic resonance imaging." J Control Release 111, no. 3, 343 - 51.
  • Yuh WT, Christoforidis GA, Koch RM, Sammet S, Schmalbrock P, Yang M, Knopp MV, 2006, "Clinical magnetic resonance imaging of brain tumors at ultrahigh field: a state-of-the-art review." Top Magn Reson Imaging 17, no. 2, 53 - 61. Review.
  • Mayr NA, Yuh WT, Taoka T, Wang JZ, Wu DH, Montebello JF, Meeks SL, Paulino AC, Magnotta VA, Adli M, Sorosky JI, Knopp MV, Buatti JM, 2006, "Serial therapy-induced changes in tumor shape in cervical cancer and their impact on assessing tumor volume and treatment response." Am J Roentgenol 187, no. 1, 65 - 72.
  • Jia G, Heverhagen JT, Henry H, Polzer H, Baudendistel KT, von Tengg-Kobligk H, Levine AL, Rosol TJ, Knopp MV, 2006, "Pharmacokinetic parameters as a potential predictor of response to pharmacotherapy in benign prostatic hyperplasia: a preclinical trial using dynamic contrast-enhanced MRI." Magn Reson Imaging 24, no. 6, 721 - 5.
  • Maravilla KR, Maldjian JA, Schmalfuss IM, Kuhn MJ, Bowen BC, Wippold FJ 2nd, Runge VM, Knopp MV, Kremer S, Wolansky LJ, Anzalone N, Essig M, Gustafsson L, 2006, "Contrast enhancement of central nervous system lesions: multicenter intraindividual crossover comparative study of two MR contrast agents." Radiology 240, no. 2, 389 - 400.
  • Jia G, Heverhagen JT, Polzer H, Jacko RV, Liang J, Zhang J, Levine AL, Rosol TJ, Knopp MV, 2006, "Dynamic contrast enhanced magnetic resonance imaging as a biological marker to noninvasively assess the effect of finasteride on prostatic suburethral microcirculation." J Urol 176, no. 5, 2299 - 304.
  • Knopp MV, Balzer T, Esser M, Kashanian FK, Paul P, Niendorf HP, 2006, "Assessment of utilization and pharmacovigilance based on spontaneous adverse event reporting of gadopentetate dimeglumine as a magnetic resonance contrast agent after 45 million administrations and 15 years of clinical use." Invest Radiol 41, no. 6, 491 - 9.
  • Giesel FL, Bischoff H, von Tengg-Kobligk H, Weber MA, Zechmann CM, Kauczor HU, Knopp MV, 2006, "Dynamic contrast-enhanced MRI of malignant pleural mesothelioma: a feasibility study of noninvasive assessment, therapeutic follow-up, and possible predictor of improved outcome." Chest 129, no. 6, 1570 - 6.

2005

  • Leach MO, Brindle KM, Evelhoch JL, Griffiths JR, Horsman MR, Jackson A, Jayson GC, Judson IR, Knopp MV, Maxwell RJ, McIntyre D, Padhani AR, Price P, Rathbone R, Rustin GJ, Tofts PS, Tozer GM, Vennart W, Waterton JC, Williams SR, Workman P, et al., 2005, "The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations." Br J Cancer 92, no. 9, 1599 - 610.
  • Jia G, Baudendistel KT, von Tengg-Kobligk H, Heverhagen JT, Polzer H, Henry H, McAuliffe MJ, Levine AL, Rosol TJ, Knopp MV, 2005, "Assessing prostate volume by magnetic resonance imaging: a comparison of different measurement approaches for organ volume analysis." Invest Radiol 40, no. 4, 243 - 8.
  • Lucht RE, Delorme S, Hei J, Knopp MV, Weber MA, Griebel J, Brix G, 2005, "Classification of signal-time curves obtained by dynamic magnetic resonance mammography: statistical comparison of quantitative methods." Invest Radiol 40, no. 7, 442 - 7.
  • Yang M, Christoforidis GA, Figueredo T, Heverhagen JT, Abduljalil A, Knopp MV, 2005, "Dosage determination of ultrasmall particles of iron oxide for the delineation of microvasculature in the Wistar rat brain." Invest Radiol 40, no. 10, 655 - 60.
  • Evelhoch J, Garwood M, Vigneron D, Knopp M, Sullivan D, Menkens A, Clarke L, Liu G, 2005, "Expanding the use of magnetic resonance in the assessment of tumor response to therapy: workshop report." Cancer Res 65, no. 16, 7041 - 4.

2004

  • Colosimo C, Knopp MV, Barreau X, Gérardin E, Kirchin MA, Guézénoc F, Lodemann KP, 2004, "A comparison of Gd-BOPTA and Gd-DOTA for contrast-enhanced MRI of intracranial tumours." Neuroradiology 46, no. 8, 655 - 65.
  • Knopp MV, Runge VM, Essig M, Hartman M, Jansen O, Kirchin MA, Moeller A, Seeberg AH, Lodemann KP, 2004, "Primary and secondary brain tumors at MR imaging: bicentric intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine." Radiology 230, no. 1, 55 - 64.
  • Knopp MV, Giesel F, von Tengg-Kobligk H, 2004, "3D MR colonography after intravenous administration of the hepatobiliary contrast agent Gd-BOPTA: bile tagging." Eur Radiol 14 Suppl 7, O80 - 3; discussion O84.
  • Baudendistel KT, Heverhagen JT, Knopp MV, 2004, "[Clinical MR at 3 Tesla: current status]." Radiologe 44, no. 1, 11 - 8. Review. German..
  • Kobayashi H, Jo SK, Kawamoto S, Yasuda H, Hu X, Knopp MV, Brechbiel MW, Choyke PL, Star RA, 2004, "Polyamine dendrimer-based MRI contrast agents for functional kidney imaging to diagnose acute renal failure." J Magn Reson Imaging 20, no. 3, 512 - 8.
  • Prince MR, Choyke PL, Knopp MV, 2004, "More on pseudohypocalcemia and gadolinium-enhanced MRI." N Engl J Med 350, no. 1, 87 - 8; author reply 87.
  • Kangarlu A, Baudendistel KT, Heverhagen JT, Knopp MV, 2004, "[Clinical high- and ultrahigh-field MR and its interaction with biological systems]." Radiologe 44, no. 1, 19 - 30. Review. German..
  • Heverhagen JT, von Tengg-Kobligk H, Baudendistel KT, Jia G, Polzer H, Henry H, Levine AL, Rosol TJ, Knopp MV, 2004, "Benign prostate hyperplasia: evaluation of treatment response with DCE MRI." MAGMA 17, no. 1, 5 - 11.

2003

  • Knopp MV, Giesel FL, von Tengg-Kobligk H, Radeleff J, Requardt M, Kirchin MA, Hentrich HR, 2003, "Contrast-enhanced MR angiography of the run-off vasculature: intraindividual comparison of gadobenate dimeglumine with gadopentetate dimeglumine." J Magn Reson Imaging 17, no. 6, 694 - 702.
  • Knopp MV, von Tengg-Kobligk H, Choyke PL, 2003, "Functional magnetic resonance imaging in oncology for diagnosis and therapy monitoring." Mol Cancer Ther 2, no. 4, 419 - 26. Review.
  • Schoenberg SO, Aumann S, Just A, Bock M, Knopp MV, Johansson LO, Ahlstrom H, 2003, "Quantification of renal perfusion abnormalities using an intravascular contrast agent (part 2): results in animals and humans with renal artery stenosis." Magn Reson Med 49, no. 2, 288 - 98.
  • Choyke PL, Knopp MV, 2003, "Pseudohypocalcemia with MR imaging contrast agents: a cautionary tale." Radiology 227, no. 3, 627 - 8.
  • Knopp MV, Bourne MW, Sardanelli F, Wasser MN, Bonomo L, Boetes C, Müller-Schimpfle M, Hall-Craggs MA, Hamm B, Orlacchio A, Bartolozzi C, Kessler M, Fischer U, Schneider G, Oudkerk M, Teh WL, Gehl HB, Salerio I, Pirovano G, La Noce A, Kirchin MA, Spinazzi, 2003, "Gadobenate dimeglumine-enhanced MRI of the breast: analysis of dose response and comparison with gadopentetate dimeglumine." Am J Roentgenol 181, no. 3, 663 - 76.
  • Helbig M, Schlemmer HP, Lumer M, Knopp MV, Dietz A, 2003, "[Dynamic magnetic resonance tomography (dMRT). It's value in advanced head-neck tumors treated with radiochemotherapy]." HNO 51, no. 11, 886 - 92.
  • Kobayashi H, Kawamoto S, Choyke PL, Sato N, Knopp MV, Star RA, Waldmann TA, Tagaya Y, Brechbiel MW, 2003, "Comparison of dendrimer-based macromolecular contrast agents for dynamic micro-magnetic resonance lymphangiography." Magn Reson Med 50, no. 4, 758 - 66.
  • Wasser K, Klein SK, Fink C, Junkermann H, Sinn HP, Zuna I, Knopp MV, Delorme S, 2003, "Evaluation of neoadjuvant chemotherapeutic response of breast cancer using dynamic MRI with high temporal resolution." Eur Radiol 13, no. 1, 80 - 7.
  • Wikström J, Wasser MN, Pattynama PM, Bonomo L, Hamm B, Del Maschio A, Knopp MV, Marchal G, Barentsz JO, Oudkerk M, Hentrich HR, Daprà M, Kirchin MA, Shen N, Spinazzi A, Ahlström H, 2003, "Gadobenate dimeglumine-enhanced magnetic resonance angiography of the pelvic arteries." Invest Radiol 38, no. 8, 504 - 15.
  • von Tengg-Kobligk H, Floemer F, Knopp MV, 2003, "[Multiphasic MR angiography as an intra-individual comparison between the contrast agents Gd-DTPA, Gd-BOPTA, and Gd-BT-DO3A]." Radiologe 43, no. 2, 171 - 8.
  • Leach MO, Brindle KM, Evelhoch JL, Griffiths JR, Horsman MR, Jackson A, Jayson G, Judson IR, Knopp MV, Maxwell RJ, McIntyre D, Padhani AR, Price P, Rathbone R, Rustin G, Tofts PS, Tozer GM, Vennart W, Waterton JC, Williams SR, Workman P, 2003, "Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trials." Br J Radiol 76 Spec No 1, S87 - 91.
  • Choyke PL, Dwyer AJ, Knopp MV, 2003, "Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging." J Magn Reson Imaging 17, no. 5, 509 - 20. Review.
  • Essig M, Waschkies M, Wenz F, Debus J, Hentrich HR, Knopp MV, 2003, "Assessment of brain metastases with dynamic susceptibility-weighted contrast-enhanced MR imaging: initial results." Radiology 228, no. 1, 193 - 9.

2002

  • Schoenberg SO, Essig M, Hallscheidt P, Sharafuddin MJ, Stolpen AH, Knopp MV, Yuh WT, 2002, "Multiphase magnetic resonance angiography of the abdominal and pelvic arteries: results of a bicenter multireader analysis." Invest Radiol 37, no. 1, 20 - 8.
  • Choyke PL, Knopp MV, Libutti SK, 2002, "Special techniques for imaging blood flow to tumors." Cancer J 8, no. 2, 109 - 18. Review.
  • Schoenberg SO, Knopp MV, Londy F, Krishnan S, Zuna I, Lang N, Essig M, Hawighorst H, Maki JH, Stafford-Johnson D, Kallinowski F, Chenevert TL, Prince MR, 2002, "Morphologic and functional magnetic resonance imaging of renal artery stenosis: a multireader tricenter study." J Am Soc Nephrol 13, no. 1, 158 - 69.
  • Knopp MV, Himmelhan N, Radeleff J, Junkermann H, Hess T, Sinn HP, Brix G, 2002, "[Comparison of methods for quantifying contrast enhancement exemplified by dynamic MRI mammography]." Radiologe 42, no. 4, 280 - 90.
  • Duran M, Schoenberg SO, Yuh WT, Knopp MV, van Kaick G, Essig M, 2002, "Cerebral arteriovenous malformations: morphologic evaluation by ultrashort 3D gadolinium-enhanced MR angiography." Eur Radiol 12, no. 12, 2957 - 64.
  • Kroencke TJ, Wasser MN, Pattynama PM, Barentsz JO, Grabbe E, Marchal G, Knopp MV, Schneider G, Bonomo L, Pennell DJ, del Maschio A, Hentrich HR, Daprà M, Kirchin MA, Spinazzi A, Taupitz M, Hamm B, 2002, "Gadobenate dimeglumine-enhanced MR angiography of the abdominal aorta and renal arteries." Am J Roentgenol 179, no. 6, 1573 - 82.
  • Costouros NG, Lorang D, Zhang Y, Miller MS, Diehn FE, Hewitt SM, Knopp MV, Li KC, Choyke PL, Alexander HR, Libutti SK, 2002, "Microarray gene expression analysis of murine tumor heterogeneity defined by dynamic contrast-enhanced MRI." Mol Imaging 1, no. 3, 301 - 8.
  • Essig M, Wenz F, Scholdei R, Brüning R, Berchtenbreiter C, Meurer M, Knopp MV, 2002, "Dynamic susceptibility contrast-enhanced echo-planar imaging of cerebral gliomas. Effect of contrast medium extravasation." Acta Radiol 43, no. 4, 354 - 9.
  • Knopp MV, Schoenberg SO, Rehm C, Floemer F, von Tengg-Kobligk H, Bock M, Hentrich HR, 2002, "Assessment of gadobenate dimeglumine for magnetic resonance angiography: phase I studies." Invest Radiol 37, no. 12, 706 - 15.

2001

  • Knopp MV, Lodemann M, Kage U, Runge VM, 2001, "[Administration of MR contrast agents outside of approved indications (off-label use]." Radiologe 41, no. 3, 296 - 302.
  • Knopp MV, Giesel FL, Marcos H, von Tengg-Kobligk H, Choyke P, 2001, "Dynamic contrast-enhanced magnetic resonance imaging in oncology." Top Magn Reson Imaging 12, no. 4, 301 - 8. Review.
  • Ho VB, Foo TK, Czum JM, Marcos H, Choyke PL, Knopp MV, 2001, "Contrast-enhanced magnetic resonance angiography: technical considerations for optimized clinical implementation." Top Magn Reson Imaging 12, no. 4, 283 - 99. Review.
  • Essig M, Metzner R, Bonsanto M, Hawighorst H, Debus J, Tronnier V, Knopp MV, van Kaick G, 2001, "Postoperative fluid-attenuated inversion recovery MR imaging of cerebral gliomas: initial results." Eur Radiol 11, no. 10, 2004 - 10.
  • Knopp MV, Giesel FL, Radeleff J, Von Tengg-Kobligk H, 2001, "Bile-tagged 3d magnetic resonance colonography after exclusive intravenous administration of gadobenate dimeglumine, a contrast agent with partial hepatobiliary excretion.." Invest Radiol 36, no. 10, 619 - 23.
  • Essig M, Hartmann M, Lodemann KP, Jansen O, Seeberg A, Runge VM, Knopp MV, 2001, "[Comparison of contrast behavior of gadobenate-dimeglumine and Gd-DTPA in intra-axial brain tumors. A double-blind randomized intraindividual cross-over study]." Radiologe 41, no. 12, 1063 - 71.
  • Brix G, Henze M, Knopp MV, Lucht R, Doll J, Junkermann H, Hawighorst H, Haberkorn U, 2001, "Comparison of pharmacokinetic MRI and [18F] fluorodeoxyglucose PET in the diagnosis of breast cancer: initial experience.." Eur Radiol 11, no. 10, 2058 - 70.
  • Lucht RE, Knopp MV, Brix G, 2001, "Classification of signal-time curves from dynamic MR mammography by neural networks." Magn Reson Imaging 19, no. 1, 51 - 7.
  • Port RE, Knopp MV, Brix G, 2001, "Dynamic contrast-enhanced MRI using Gd-DTPA: interindividual variability of the arterial input function and consequences for the assessment of kinetics in tumors." Magn Reson Med 45, no. 6, 1030 - 8.

2000

  • Lucht R, Knopp MV, Brix G, 2000, "Elastic matching of dynamic MR mammographic images." Magn Reson Med 43, no. 1, 9 - 16.
  • Floemer F, Glombitza G, Knopp MV, Schoenberg SO, Brockmeier K, Meinzer HP, 2000, "[Use of virtual reality for MRI data of complex vascular structures]." Radiologe 40, no. 3, 246 - 55.
  • Englmeier KH, Griebel J, Lucht R, Knopp M, Siebert M, Brix G, 2000, "[Dynamic MR mammography. Multidimensional visualization of contrast medium enhancement in virtual reality]." Radiologe 40, no. 3, 262 - 6.
  • Brix G, Henze M, Doll J, Lucht R, Zaers J, Trojan H, Knopp MV, Haberkorn U, 2000, "[Diagnostic evaluation of the breast using PET: optimization of data acquisition and postprocessing]." Nuklearmedizin 39, no. 3, 62 - 6.
  • Essig M, Wenz F, Schoenberg SO, Debus J, Knopp MV, van Kaick G, 2000, "Arteriovenous malformations: assessment of gliotic and ischemic changes with fluid-attenuated inversion-recovery MRI." Invest Radiol 35, no. 11, 689 - 94.
  • Schoenberg SO, Floemer F, Kroeger H, Hoffmann A, Bock M, Knopp MV, 2000, "Combined assessment of obstructive sleep apnea syndrome with dynamic MRI and parallel EEG registration: initial results." Invest Radiol 35, no. 4, 267 - 76.
  • Fuss M, Wenz F, Scholdei R, Essig M, Debus J, Knopp MV, Wannenmacher M, 2000, "Radiation-induced regional cerebral blood volume (rCBV) changes in normal brain and low-grade astrocytomas: quantification and time and dose-dependent occurrence." Int J Radiat Oncol Biol Phys 48, no. 1, 53 - 8.
  • Schoenberg SO, Bock M, Aumann S, Just A, Essig M, Floemer F, Knopp MV, van Kaick G, 2000, "[Quantitative recording of renal function with magnetic resonance tomography]." Radiologe 40, no. 10, 925 - 37. Review.
  • Bruening R, Berchtenbreiter C, Holzknecht N, Essig M, Wu RH, Simmons A, Heuck A, Maschek A, Meusel M, Williams SC, Cox T, Knopp MV, Reiser M, 2000, "Effects of three different doses of a bolus injection of gadodiamide: assessment of regional cerebral blood volume maps in a blinded reader study." Am J Neuroradiol 21, no. 9, 1603 - 10.
  • Essig M, Deimling M, Schoenberg SO, Debus J, Knopp MV, van Kaick G, 2000, "[HIRE (high intensity reduction). New cerebrospinal fluid suppressed T2-weighted imaging sequence]." Radiologe 40, no. 12, 1163 - 71.
  • Knopp MV, von Hippel GM, Koch T, Knopp MA, 2000, "[Intranet applications in radiology]." Radiologe 40, no. 1, 78 - 82.

1999

  • Runge VM, Knopp MV, 1999, "Off-label use and reimbursement of contrast media in MR." J Magn Reson Imaging 10, no. 3, 489 - 95.
  • Schoenberg SO, Knopp MV, Bock M, Floemer F, Kallinowski F, Essig M, Hawighorst H, Just A, Laub G, Prince MR, van Kaick G, 1999, "[MRI of the kidneys. New diagnostic strategies]." Radiologe 39, no. 5, 373 - 85.
  • Lohr F, Essig M, Bock M, Oster H, Wenz F, Knopp MV, 1999, "Ventricular arrhythmia during MR angiography with fast ramping gradients in a patient with multiple coronary artery bypass grafts (CABG)." J Magn Reson Imaging 9, no. 4, 624 - 6.
  • Hawighorst H, Knapstein PG, Knopp MV, Vaupel P, van Kaick G, 1999, "Cervical carcinoma: standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival.." MAGMA 8, no. 1, 55 - 62.
  • Essig M, Knopp MV, Debus J, Schönberg SO, Wenz F, Hawighorst H, van Kaick G, 1999, "[Fluid-attenuated-inversion-recovery (FLAIR) imaging in the diagnosis of cerebral gliomas and metastases]." Radiologe 39, no. 2, 151 - 60. Review.
  • Schlemmer HP, Becker M, Bachert P, Dietz A, Rudat V, Vanselow B, Wollensack P, Zuna I, Knopp MV, Weidauer H, Wannenmacher M, van Kaick G, 1999, "Alterations of intratumoral pharmacokinetics of 5-fluorouracil in head and neck carcinoma during simultaneous radiochemotherapy." Cancer Res 59, no. 10, 2363 - 9.
  • Taylor JS, Tofts PS, Port R, Evelhoch JL, Knopp M, Reddick WE, Runge VM, Mayr N, 1999, "MR imaging of tumor microcirculation: promise for the new millennium." J Magn Reson Imaging 10, no. 6, 903 - 7.
  • Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, Larsson HB, Lee TY, Mayr NA, Parker GJ, Port RE, Taylor J, Weisskoff RM, 1999, "Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols." J Magn Reson Imaging 10, no. 3, 223 - 32. Review.
  • Port RE, Knopp MV, Hoffmann U, Milker-Zabel S, Brix G, 1999, "Multicompartment analysis of gadolinium chelate kinetics: blood-tissue exchange in mammary tumors as monitored by dynamic MR imaging." J Magn Reson Imaging 10, no. 3, 233 - 41.
  • Mayr NA, Hawighorst H, Yuh WT, Essig M, Magnotta VA, Knopp MV, 1999, "MR microcirculation assessment in cervical cancer: correlations with histomorphological tumor markers and clinical outcome." J Magn Reson Imaging 10, no. 3, 267 - 76. Review.
  • Hawighorst H, Libicher M, Knopp MV, Moehler T, Kauffmann GW, van Kaick G, 1999, "Evaluation of angiogenesis and perfusion of bone marrow lesions: role of semiquantitative and quantitative dynamic MRI." J Magn Reson Imaging 10, no. 3, 286 - 94.
  • Essig M, Knopp MV, Schoenberg SO, Hawighorst H, Wenz F, Debus J, van Kaick G, 1999, "Cerebral gliomas and metastases: assessment with contrast-enhanced fast fluid-attenuated inversion-recovery MR imaging." Radiology 210, no. 2, 551 - 7.
  • Hawighorst H, Schoenberg SO, Knopp MV, Essig M, Miltner P, van Kaick G, 1999, "Hepatic lesions: morphologic and functional characterization with multiphase breath-hold 3D gadolinium-enhanced MR angiography--initial results." Radiology 210, no. 1, 89 - 96.
  • Knopp MV, Floemer F, Schoenberg SO, von Tengg-Kobligk H, Bock M, van Kaick G, 1999, "Non-invasive assessment of renal artery stenosis: current concepts and future directions in magnetic resonance angiography." J Comput Assist Tomogr 23 Suppl 1, S111 - 7. Review.
  • Schoenberg SO, Wunsch C, Knopp MV, Essig M, Hawighorst H, Laub G, Prince MR, Allenberg JR, Van Kaick G, 1999, "Abdominal aortic aneurysm. Detection of multilevel vascular pathology by time-resolved multiphase 3D gadolinium MR angiography: initial report." Invest Radiol 34, no. 10, 648 - 59.
  • Knopp MV, von Tengg-Kobligk H, Floemer F, Schoenberg SO, 1999, "Contrast agents for MRA: future directions." J Magn Reson Imaging 10, no. 3, 314 - 6. Review.
  • Knopp MV, Weiss E, Sinn HP, Mattern J, Junkermann H, Radeleff J, Magener A, Brix G, Delorme S, Zuna I, van Kaick G, 1999, "Pathophysiologic basis of contrast enhancement in breast tumors." J Magn Reson Imaging 10, no. 3, 260 - 6.
  • Pantel J, Schröder J, Jauss M, Essig M, Minakaran R, Schönknecht P, Schneider G, Schad LR, Knopp MV, 1999, "Topography of callosal atrophy reflects distribution of regional cerebral volume reduction in Alzheimer's disease." Psychiatry Res 90, no. 3, 181 - 92.
  • Schoenberg SO, Bock M, Floemer F, Grau A, Williams DM, Laub G, Knopp MV, 1999, "High-resolution pulmonary arterio- and venography using multiple-bolus multiphase 3D-Gd-mRA." J Magn Reson Imaging 10, no. 3, 339 - 46.
  • Schröder J, Essig M, Baudendistel K, Jahn T, Gerdsen I, Stockert A, Schad LR, Knopp MV, 1999, "Motor dysfunction and sensorimotor cortex activation changes in schizophrenia: A study with functional magnetic resonance imaging.." Neuroimage 9, no. 1, 81 - 7.
  • Schoenberg SO, Bock M, Knopp MV, Essig M, Laub G, Hawighorst H, Zuna I, Kallinowski F, van Kaick G, 1999, "Renal arteries: optimization of three-dimensional gadolinium-enhanced MR angiography with bolus-timing-independent fast multiphase acquisition in a single breath hold." Radiology 211, no. 3, 667 - 79.
  • Scholdei R, Wenz F, Essig M, Fuss M, Knopp MV, 1999, "[The simultaneous determination of the arterial input function for dynamic susceptibility-weighted magnetic resonance tomography of the A. carotis interna and the A. cerebri media]." Rofo 171, no. 1, 38 - 43.
  • Schoenberg SO, Essig M, Bock M, Hawighorst H, Sharafuddin M, Knopp MV, 1999, "Comprehensive MR evaluation of renovascular disease in five breath holds." J Magn Reson Imaging 10, no. 3, 347 - 56.

1998

  • Hawighorst H, Schaeffer U, Knapstein PG, Knopp MV, Weikel W, Schönberg SO, Essig M, van Kaick G, 1998, "[Detection of angiogenesis-dependent parameters by functional MRI: correlation with histomorphology and evaluation of clinical relevance as prognostic factor using cervix carcinoma as an example]." Rofo 169, no. 5, 499 - 504.
  • Hawighorst H, Knapstein PG, Knopp MV, Weikel W, Brix G, Zuna I, Schönberg SO, Essig M, Vaupel P, van Kaick G, 1998, "Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival." Cancer Res 58, no. 16, 3598 - 602.
  • Hawighorst H, Weikel W, Knapstein PG, Knopp MV, Zuna I, Schönberg SO, Vaupel P, van Kaick G, 1998, "Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome." Clin Cancer Res 4, no. 10, 2305 - 12.
  • Schoenberg SO, Knopp MV, Bock M, Prince MR, Allenberg JR, 1998, "Combined morphologic and functional assessment of renal artery stenosis using gadolinium enhanced magnetic resonance imaging." Nephrol Dial Transplant 13, no. 11, 2738 - 42.
  • Pantel J, Schröder J, Essig M, Schad LR, Popp D, Eysenbach K, Jauss M, Knopp MV, 1998, "[Volumetric brain findings in late depression. A study with quantified magnetic resonance tomography]." Nervenarzt 69, no. 11, 968 - 74.
  • Hawighorst H, Dörsam J, Knopp MV, Jugowski W, Schoenberg SO, Wiesel M, Essig M, van Kaick G, 1998, "[MR tomographic monitoring of prostate carcinoma after cryotherapy: initial results]." Rofo 168, no. 1, 44 - 8.
  • Hawighorst H, Knapstein PG, Knopp MV, Weikel W, Schaeffer U, Zuna I, Schönberg SO, Essig M, Hoffmann U, Brix G, van Kaick G, 1998, "[Angiogenesis of cervix carcinoma. Contrast enhanced dynamic MRI, histologic quantification of capillary density and lymphatic system infiltration]." Radiologe 38, no. 1, 50 - 7.
  • Delorme S, Knopp MV, 1998, "Non-invasive vascular imaging: assessing tumour vascularity." Eur Radiol 8, no. 4, 517 - 27. Review.
  • Pantel J, Schröder J, Essig M, Minakaran R, Schad LR, Friedlinger M, Jauss M, Knopp MV, 1998, "Corpus callosum in Alzheimer's disease and vascular dementia--a quantitative magnetic resonance study." J Neural Transm Suppl 54, 129 - 36.
  • Hawighorst H, Schoenberg SO, Knapstein PG, Knopp MV, Schaeffer U, Essig M, van Kaick G, 1998, "Staging of invasive cervical carcinoma and of pelvic lymph nodes by high resolution MRI with a phased-array coil in comparison with pathological findings." J Comput Assist Tomogr 22, no. 1, 75 - 81.
  • Pantel J, Schröder J, Essig M, Jauss M, Schneider G, Eysenbach K, von Kummer R, Baudendistel K, Schad LR, Knopp MV, 1998, "In vivo quantification of brain volumes in subcortical vascular dementia and Alzheimer's disease. An MRI-based study.." Dement Geriatr Cogn Disord 9, no. 6, 309 - 16.
  • Essig M, Hawighorst H, Schoenberg SO, Engenhart-Cabillic R, Fuss M, Debus J, Zuna I, Knopp MV, van Kaick G, 1998, "Fast fluid-attenuated inversion-recovery (FLAIR) MRI in the assessment of intraaxial brain tumors." J Magn Reson Imaging 8, no. 4, 789 - 98.
  • Hawighorst H, Knopp MV, Debus J, Hoffmann U, Grandy M, Griebel J, Zuna I, Essig M, Schoenberg SO, DeVries A, Brix G, van Kaick G, 1998, "Pharmacokinetic MRI for assessment of malignant glioma response to stereotactic radiotherapy: initial results." J Magn Reson Imaging 8, no. 4, 783 - 8.
  • Bock M, Schoenberg SO, Schad LR, Knopp MV, Essig M, van Kaick G, 1998, "Interleaved gradient echo planar (IGEPI) and phase contrast CINE-PC flow measurements in the renal artery.." J Magn Reson Imaging 8, no. 4, 889 - 95.
  • Schoenberg SO, Knopp MV, Prince MR, Londy F, Knopp MA, 1998, "Arterial-phase three-dimensional gadolinium magnetic resonance angiography of the renal arteries. Strategies for timing and contrast media injection: original investigation.." Invest Radiol 33, no. 9, 506 - 14.
  • Hawighorst H, Bock M, Knopp MV, Essig M, Schoenberg SO, Knapstein PG, Schad LR, van Kaick G, 1998, "[MRI imaging of the uterine arterial blood flow in normal and malignant uterine tissue by means of 2d-multiphase tagging technic]." Radiologe 38, no. 6, 539 - 44.
  • Schoenberg SO, Prince MR, Knopp MV, Allenberg JR, 1998, "Renal MR angiography." Magn Reson Imaging Clin N Am 6, no. 2, 351 - 70.
  • Hawighorst H, Bock M, Knopp MV, Essig M, Schoenberg SO, Knapstein PG, Schad LR, van Kaick G, 1998, "Magnetically labeled water perfusion imaging of the uterine arteries and of normal and malignant cervical tissue: initial experiences.." Magn Reson Imaging 16, no. 3, 225 - 34.
  • Knopp MV, Floemer F, Zuna I, van Kaick G, 1998, "[Study design in clinical radiologic research]." Radiologe 38, no. 4, 241 - 7.
  • Knopp MV, Obier C, Zuna I, Junkermann H, Hess T, Junkermann I, Brix G, van Kaick G, 1998, "[Multiple reader analysis for evaluation of functional MR mammography]." Radiologe 38, no. 4, 307 - 14.
  • Knopp MV, Metzner R, Brix G, van Kaick G, 1998, "[Safety considerations to avoid current-induced skin burns in MRI procedures]." Radiologe 38, no. 9, 759 - 63.
  • Schoenberg SO, Knopp MV, Grau A, Bischoff H, Bock M, Schlemmer HP, Hawighorst H, Laub G, Kosmaoglou P, van Kaick G, 1998, "[Ultrafast MRI phlebography of the lungs]." Radiologe 38, no. 7, 597 - 605.

1997

  • Essig M, Knopp MV, Hawighorst H, van Kaick G, 1997, "MRI of capillary hemangioma of the testis." J Comput Assist Tomogr 21, no. 3, 402 - 4.
  • Schoenberg SO, Just A, Bock M, Knopp MV, Persson PB, Kirchheim HR, 1997, "Noninvasive analysis of renal artery blood flow dynamics with MR cine phase-contrast flow measurements." Am J Physiol 272, no. 5 Pt 2, H2477 - 84.
  • Pantel J, Schröder J, Schad LR, Friedlinger M, Knopp MV, Schmitt R, Geissler M, Blüml S, Essig M, Sauer H, 1997, "Quantitative magnetic resonance imaging and neuropsychological functions in dementia of the Alzheimer type." Psychol Med 27, no. 1, 221 - 9.
  • Knopp MV, Essig M, Hawighorst H, Wenz F, Brix G, Schad LR, Bachert P, van Kaick G, 1997, "Functional neuroimaging in the assessment of CNS neoplasms." Eur Radiol 7 Suppl 5, 209 - 15. Review.
  • Hawighorst H, Debus J, Schreiber W, Knopp MV, Engenhart-Cabillic R, Essig M, Brix G, van Kaick G, 1997, "Contrast-enhanced magnetization transfer imaging: improvement of brain tumor conspicuity and delineation for radiosurgical target volume definition." Radiother Oncol 43, no. 3, 261 - 7.
  • Schad LR, Bachert P, Bock M, Essig M, Knopp MV, Ebert M, Grossmann T, Heil W, Surkau R, Otten EW, 1997, "Hyperpolarized gases--a new type of MR contrast agents?." Acta Radiol Suppl 412, 43 - 6.
  • Schulze A, Hess T, Wevers R, Mayatepek E, Bachert P, Marescau B, Knopp MV, De Deyn PP, Bremer HJ, Rating D, 1997, "Creatine deficiency syndrome caused by guanidinoacetate methyltransferase deficiency: diagnostic tools for a new inborn error of metabolism." J Pediatr 131, no. 4, 626 - 31.
  • Hawighorst H, Knopp MV, Debus J, Brix G, Engenhart-Cabillic R, Schad LR, Grandy M, Essig M, van Kaick G, 1997, "[Morphologic MR imaging with T1-weighted sequences for radiotherapy goal volume definition of intracranial tumors. Comparison with FLASH-Turbo-FLASH and SE sequences]." Radiologe 37, no. 3, 243 - 50.
  • Schoenberg SO, Knopp MV, Bock M, Kallinowski F, Just A, Essig M, Hawighorst H, Schad L, van Kaick G, 1997, "Renal artery stenosis: grading of hemodynamic changes with cine phase-contrast MR blood flow measurements." Radiology 203, no. 1, 45 - 53.
  • Pantel J, Schröder J, Essig M, Popp D, Dech H, Knopp MV, Schad LR, Eysenbach K, Backenstrass M, Friedlinger M, 1997, "Quantitative magnetic resonance imaging in geriatric depression and primary degenerative dementia.." J Affect Disord 42, no. 1, 69 - 83.
  • Griebel J, Mayr NA, de Vries A, Knopp MV, Gneiting T, Kremser C, Essig M, Hawighorst H, Lukas PH, Yuh WT, 1997, "Assessment of tumor microcirculation: a new role of dynamic contrast MR imaging." J Magn Reson Imaging 7, no. 1, 111 - 9.
  • Brix G, Schreiber W, Hoffmann U, Gückel F, Hawighorst H, Knopp MV, 1997, "[Methodological approaches to quantitative evaluation of microcirculation in tissues with dynamic magnetic resonance tomography]." Radiologe 37, no. 6, 470 - 80.
  • Schoenberg SO, Knopp MV, Bock M, Kallinowski F, Just A, Essig M, Hawighorst H, Zuna I, Schad L, Allenberg JR, van Kaick G, 1997, "[Classification of hemodynamic changes in renal artery stenosis using cine magnetic resonance phase contrast flow measurements]." Radiologe 37, no. 8, 651 - 62.
  • Knopp MV, Dörsam J, Oesingmann N, Piesche S, Hawighorst H, Wiesel M, Schad LR, van Kaick G, 1997, "[Functional MR urography in patients with kidney transplantation]." Radiologe 37, no. 3, 233 - 8.
  • Hawighorst H, Knapstein PG, Weikel W, Knopp MV, Schaeffer U, Essig M, Brix G, Zuna I, Schönberg S, van Kaick G, 1997, "[Invasive cervix carcinoma (pT2b-pT4a). Value of conventional and pharmacokinetic magnetic resonance tomography (MRI) in comparison with extensive cross sections and histopathologic findings]." Radiologe 37, no. 2, 130 - 8.
  • Dörsam J, Knopp MV, Carl S, Oesingmann N, Schad L, Brkovic D, van Kaick G, Staehler G, 1997, "Ureteral complications after kidney transplantation--evaluation with functional magnetic resonance urography." Transplant Proc 29, no. 1-2, 132 - 5.
  • Hawighorst H, Knapstein PG, Weikel W, Knopp MV, Zuna I, Knof A, Brix G, Schaeffer U, Wilkens C, Schoenberg SO, Essig M, Vaupel P, van Kaick G, 1997, "Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement." Cancer Res 57, no. 21, 4777 - 86.
  • Dörsam J, Knopp MV, Oesingmann N, Schad L, Brkovic D, van Kaick G, Staehler G, 1997, "[Magnetic resonance urography. First clinical results]." Urologe A 36, no. 2, 173 - 6.
  • Hawighorst H, Engenhart R, Knopp MV, Brix G, Grandy M, Essig M, Miltner P, Zuna I, Fuss M, van Kaick G, 1997, "Intracranial meningeomas: time- and dose-dependent effects of irradiation on tumor microcirculation monitored by dynamic MR imaging." Magn Reson Imaging 15, no. 4, 423 - 32.
  • Hawighorst H, Essig M, Debus J, Knopp MV, Engenhart-Cabilic R, Schönberg SO, Brix G, Zuna I, van Kaick G, 1997, "Serial MR imaging of intracranial metastases after radiosurgery." Magn Reson Imaging 15, no. 10, 1121 - 32.
  • Hawighorst H, Schreiber W, Debus J, Knopp MV, Engenhart-Cabillic R, Brix G, Essig M, van Kaick G, 1997, "[Contrast-enhanced MR "magnetization transfer technique". Improved tumor contrast, delineation and visibility of intracranial malignant gliomas and metastases in radiosurgical treatment planning]." Strahlenther Onkol 173, no. 12, 684 - 92.
  • Schröder J, Pantel J, Ida N, Essig M, Hartmann T, Knopp MV, Schad LR, Sandbrink R, Sauer H, Masters CL, Beyreuther K, 1997, "Cerebral changes and cerebrospinal fluid beta-amyloid in Alzheimer's disease: a study with quantitative magnetic resonance imaging." Mol Psychiatry 2, no. 6, 505 - 7.
  • Kallinowski F, Schönberg S, Bock M, Knopp MV, Clorius J, Allenberg JR, 1997, "[Detection of the hemodynamic effects of renal artery stenosis with MRI flow measurement]." Langenbecks Arch Chir Suppl Kongressbd 114, 443 - 4.

1996

  • Hawighorst H, Knapstein PG, Weikel W, Knopp MV, Schaeffer U, Brix G, Essig M, Hoffmann U, Zuna I, Schönberg S, van Kaick G, 1996, "Cervical carcinoma: comparison of standard and pharmacokinetic MR imaging." Radiology 201, no. 2, 531 - 9.
  • Debus J, Engenhart-Cabillic R, Knopp MV, Schad LR, Schlegel W, Wannenmacher M, 1996, "[Image-oriented planning of minimally invasive conformal irradiation of the head-neck area]." Radiologe 36, no. 9, 732 - 6.
  • Ebert M, Grossmann T, Heil W, Otten WE, Surkau R, Leduc M, Bachert P, Knopp MV, Schad LR, Thelen M, 1996, "Nuclear magnetic resonance imaging with hyperpolarised helium-3." Lancet 347, no. 9011, 1297 - 9.
  • Wenz F, Fuss M, Scholdei R, Essig M, Lohr F, Rempp K, Brix G, Knopp MV, Engenhart R, Wannenmacher M, 1996, "[Blood volume changes after the radiotherapy of the central nervous system]." Strahlenther Onkol 172, no. 10, 559 - 66.
  • Delorme S, Knopp MV, Kauczor HU, Raue F, Buhr H, van Kaick G, 1996, "An optimized examination protocol for contrast-enhanced cervical and mediastinal CT." Clin Imaging 20, no. 1, 31 - 6.
  • Debus J, Essig M, Schad LR, Wenz F, Baudendistel K, Knopp MV, Engenhart R, Lorenz WJ, 1996, "Functional magnetic resonance imaging in a stereotactic setup." Magn Reson Imaging 14, no. 9, 1007 - 12.
  • Essig M, Engenhart R, Knopp MV, Bock M, Scharf J, Debus J, Wenz F, Hawighorst H, Schad LR, van Kaick G, 1996, "Cerebral arteriovenous malformations: improved nidus demarcation by means of dynamic tagging MR-angiography." Magn Reson Imaging 14, no. 3, 227 - 33.
  • Schad LR, Bock M, Baudendistel K, Essig M, Debus J, Knopp MV, Engenhart R, Lorenz WJ, 1996, "Improved target volume definition in radiosurgery of arteriovenous malformations by stereotactic correlation of MRA, MRI, blood bolus tagging, and functional MRI." Eur Radiol 6, no. 1, 38 - 45.
  • Pantel J, Schröder J, Schmitt R, Schad LR, Knopp MV, Geissler M, Uhde WH, Blüml S, Friedlinger M, Klemenz M, Essig M, Sauer H, 1996, "[Quantitative magnetic resonance tomography and the severity of deficits in dementia of the Alzheimer type]." Nervenarzt 67, no. 1, 46 - 52.
  • Blüml S, Schad LR, Scharf J, Wenz F, Knopp MV, Lorenz WJ, 1996, "A comparison of magnetization prepared 3D gradient-echo (MP-RAGE) sequences for imaging of intracranial lesions." Magn Reson Imaging 14, no. 3, 329 - 35.
  • Baudendistel KT, Schad LR, Wenz F, Essig M, Schröder J, Jahn T, Knopp MV, Lorenz WJ, 1996, "Monitoring of task performance during functional magnetic resonance imaging of sensorimotor cortex at 1.5 T." Magn Reson Imaging 14, no. 1, 51 - 8.
  • Knopp MV, Bischoff H, Rimac A, Oberdorfer F, van Kaick G, 1996, "Bone marrow uptake of fluorine-18-fluorodeoxyglucose following treatment with hematopoietic growth factors: initial evaluation." Nucl Med Biol 23, no. 6, 845 - 9.
  • Hawighorst H, Schreiber W, Knopp MV, Essig M, Engenhart-Cabilic R, Brix G, van Kaick G, 1996, "Macroscopic tumor volume of malignant glioma determined by contrast-enhanced magnetic resonance imaging with and without magnetization transfer contrast." Magn Reson Imaging 14, no. 10, 1119 - 26.
  • Knopp MV, Essig M, Debus J, Zabel HJ, van Kaick G, 1996, "Unusual burns of the lower extremities caused by a closed conducting loop in a patient at MR imaging." Radiology 200, no. 2, 572 - 5.
  • Schreiber WG, Brix G, Knopp MV, Hess T, Lorenz WJ, 1996, "Improved visualization of breast lesions with gadolinium-enhanced magnetization transfer MR imaging." Magn Reson Med 35, no. 6, 861 - 9.
  • Hawighorst H, Knapstein PG, Schaeffer U, Knopp MV, Brix G, Hoffmann U, Zuna I, Essig M, van Kaick G, 1996, "Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditions." Am J Roentgenol 166, no. 2, 401 - 8.
  • Knopp MV, Bock M, 1996, "[The internet data highway. Are there radiologic applications?]." Radiologe 36, no. 1, 92 - 5.
  • Bachert P, Schad LR, Bock M, Knopp MV, Ebert M, Grossmann T, Heil W, Hofmann D, Surkau R, Otten EW, 1996, "Nuclear magnetic resonance imaging of airways in humans with use of hyperpolarized 3He.." Magn Reson Med 36, no. 2, 192 - 6.
  • Wenz F, Rempp K, Hess T, Debus J, Brix G, Engenhart R, Knopp MV, van Kaick G, Wannenmacher M, 1996, "Effect of radiation on blood volume in low-grade astrocytomas and normal brain tissue: quantification with dynamic susceptibility contrast MR imaging." Am J Roentgenol 166, no. 1, 187 - 93.
  • Knopp MV, 1996, "[Response evaluation with functional magnetic resonance mammography]." Zentralbl Gynakol 118, no. 10, 571 - 2.
  • Kauczor HU, Hofmann D, Kreitner KF, Nilgens H, Surkau R, Heil W, Potthast A, Knopp MV, Otten EW, Thelen M, 1996, "Normal and abnormal pulmonary ventilation: visualization at hyperpolarized He-3 MR imaging." Radiology 201, no. 2, 564 - 8.
  • Wenz F, Rempp K, Brix G, Knopp MV, Gückel F, Hess T, van Kaick G, 1996, "Age dependency of the regional cerebral blood volume (rCBV) measured with dynamic susceptibility contrast MR imaging (DSC)." Magn Reson Imaging 14, no. 2, 157 - 62.
  • Hess T, Stepanow B, Knopp MV, 1996, "Safety of intrauterine contraceptive devices during MR imaging.." Eur Radiol 6, no. 1, 66 - 8.

1995

  • Hawighorst H, Knapstein PG, Schaeffer U, Brix G, Weikel P, Essig M, Zuna I, Knopp MV, 1995, "[Diagnosis of recurrence of cervix carcinoma using dynamic MRI: correlation of pharmacokinetic analysis and histopathology]." Radiologe 35, no. 12, 945 - 51.
  • Hoffmann U, Brix G, Knopp MV, Hess T, Lorenz WJ, 1995, "Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography." Magn Reson Med 33, no. 4, 506 - 14.
  • Wenz F, Baudendistel K, Knopp MV, Schad LR, Schröder J, Flömer F, van Kaick G, 1995, "[Functional magnetic resonance tomography of movement disorders in patients with schizophrenia]." Radiologe 35, no. 4, 267 - 71.
  • Wenz F, Baudendistel K, Wildermuth S, Hess T, Egelhof T, Forsting M, Schad LR, Knopp MV, 1995, "Quantifizierung der hemisphärischen Asymmetrie bei Fingerbewegung mit der funktionellen Magnetresonanztomographie." Klinische Neuroradiologie 5, no. 2, 53 - 60.
  • Dörsam J, Knopp MV, Schad L, Piesche S, Carl S, Oesingmann N, 1995, "Elimination of gadolinium-DTPA by peritoneal dialysis." Nephrol Dial Transplant 10, no. 7, 1228 - 30.
  • Delorme S, Zuna I, Huber S, Albert B, Lohr F, Knopp MV, Junkermann H, van Kaick G, 1995, "Farb-Dopplersonographie bei Mammatumoren: Quantifizierung durch computergestutzte Verfahren.." Tumordiagn U Ther 16, 180 - 6.
  • Knopp MV, Hoffmann U, Brix G, Hawighorst H, Junkermann HJ, van Kaick G, 1995, "[Fast MRI contrast medium dynamics for characterization of tumors. Experiences with functional MR-mammography]." Radiologe 35, no. 12, 964 - 72.
  • Schröder J, Wenz F, Schad LR, Baudendistel K, Knopp MV, 1995, "Sensorimotor cortex and supplementary motor area changes in schizophrenia. A study with functional magnetic resonance imaging." Br J Psychiatry 167, no. 2, 197 - 201.
  • Sijens PE, Knopp MV, Brunetti A, Wicklow K, Alfano B, Bachert P, Sanders JA, Stillman AE, Kett H, Sauter R, et al, 1995, "1H MR spectroscopy in patients with metastatic brain tumors: a multicenter study.." Magn Reson Med 33, no. 6, 818 - 26.
  • Knopp MV, Kauczor HU, Knopp MA, Manella P, Delorme S, Wenz F, 1995, "[Effects of viscosity, cannula size and temperature in mechanical contrast media administration in CT and magnetic resonance tomography]." Rofo 163, no. 3, 259 - 64.
  • Knopp MV, Knopp MA, 1995, "[PC applications in routine practice, science and teaching. What computer peripherals are useful?]." Radiologe 35, no. 9, 620 - 4. Review.
  • Knopp MV, Junkermann H, Sinn HP, 1995, "[Monstrous breast tumor]." Radiologe 35, no. 5, 363 - 6.

1994

  • Huber S, Delorme S, Knopp MV, Junkermann H, Zuna I, von Fournier D, van Kaick G, 1994, "Breast tumors: computer-assisted quantitative assessment with color Doppler US." Radiology 192, no. 3, 797 - 801.
  • Knopp MV, Bischoff H, Lorenz WJ, Van Kaick G, 1994, "PET imaging of lung tumours and mediastinal lymphoma." Nucl Med Biol 21, no. 5, 749 - 57.
  • Schlemmer HP, Hess T, Debus J, Knopp MV, Schad LR, Engenhart R, 1994, "[TOF-MR angiography in radiotherapy treated cerebral arteriovenous malformations]." Radiologe 34, no. 8, 447 - 53.
  • Knopp MV, 1994, "[CD-ROM for radiologic literature research]." Radiologe 34, no. 9, 557 - 60.
  • Hess T, Knopp MV, Hoffmann U, Brix G, Junkermann H, Zuna I, von Fournier D, van Kaick G, 1994, "[A pharmacokinetic analysis of Gd-DTPA enhancement in MRT in breast carcinoma]." Rofo 160, no. 6, 518 - 23.
  • Wacker CM, Schad LR, Gehling U, Gamroth AH, Müller E, Knopp MV, Schulz V, van Kaick G, 1994, "The pulmonary artery acceleration time determined with the MR-RACE-technique: comparison to pulmonary artery mean pressure in 12 patients." Magn Reson Imaging 12, no. 1, 25 - 31.
  • Danes J, Knopp MV, Zuna I, van Kaick G, 1994, "MR mamografie (magnetická rezonance prsu). Historie a soucasnost." Ces Radiol 48, no. 2, 92 - 6.
  • Wenz F, Schad LR, Knopp MV, Baudendistel KT, Flömer F, Schröder J, van Kaick G, 1994, "Functional magnetic resonance imaging at 1.5 T: activation pattern in schizophrenic patients receiving neuroleptic medication.." Magn Reson Imaging 12, no. 7, 975 - 82.
  • Wenz F, Hess T, Knopp MV, Weisser G, Blüml S, Schad LR, Hawighorst H, van Kaick G, 1994, "3D MPRAGE evaluation of lesions in the posterior cranial fossa." Magn Reson Imaging 12, no. 4, 553 - 8.
  • Knopp MV, Hess T, Schad LR, Bischoff HG, Weisser G, Blüml S, van Kaick G, 1994, "[MR tomography of lung metastases with rapid gradient echo sequences. Initial results in diagnostic applications]." Radiologe 34, no. 10, 581 - 7.
  • Schad LR, Wenz F, Knopp MV, Baudendistel K, Müller E, Lorenz WJ, 1994, "Functional 2D and 3D magnetic resonance imaging of motor cortex stimulation at high spatial resolution using standard 1.5 T imager." Magn Reson Imaging 12, no. 1, 9 - 15.
  • Knopp MV, Brix G, Junkermann HJ, Sinn HP, 1994, "MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy." Magn Reson Imaging Clin N Am 2, no. 4, 633 - 58.
  • Knopp MV, Bischoff HG, 1994, "[Evaluation of pulmonary lesions with positron emission tomography]." Radiologe 34, no. 10, 588 - 91.
  • Betsch B, Berndt R, Knopp MV, Schmähl A, Trost U, Delorme S, 1994, "[Comparison of computerized tomography and B-image ultrasound in imaging diagnosis of the mediastinum]." Bildgebung 61, no. 4, 295 - 8.
  • Niethammer R, Karr M, Schad LR, Knopp MV, Wenz F, Stockert A, Baudendistel K, Schroder J, 1994, "Schizophrene Psychosen. Morphologische und funktionelle Veränderungen." TW Neurologie Psychiatrie 8, 679 - 86.
  • Hess T, Muller-Schimpfle M, Brix G, Junkermann H, Heiland S, Knopp MV, van Kaick G, Semmler W, 1994, "Dynamic Gd-DTPA Enhanced MRI in the Follow-Up of Cervical Carcinoma after Combined Radio/Chemotherapy." Adv MRI Contrast 2, no. 3-4, 85 - 93.
  • Ende G, Bachert P, Kolem H, Blankenhorn M, Semmler W, Knopp MV, Lorenz WJ, 1994, "Metabolische Bildgebung am Gehirn des Menschen mittels lokalisierter in vivo 31P-1H-Doppelresonanz-Spektroskopie." Z Med Phys 4, 14 - 20.

1993

  • Delorme S, Anton HW, Knopp MV, Zuna I, Junkermann H, von Fournier D, van Kaick G, 1993, "Breast Cancer: Assessment of Vascularity by Color Doppler." Eur Radiol 3, 253 - 7.
  • Knopp MV, Hess T, Bachert P, Ende G, Junkermann H, Hesterkamp T, van Kaick G, 1993, "[Magnetic resonance spectroscopy of breast cancer]." Radiologe 33, no. 5, 300 - 7. Review.
  • Kauczor HU, Dieti B, Brix G, Jarosch K, Knopp MV, van Kaick G, 1993, "Fatty replacement of bone marrow after radiation therapy for Hodgkin disease: quantification with chemical shift imaging." J Magn Reson Imaging 3, no. 4, 575 - 80.
  • Schad LR, Trost U, Knopp MV, Müller E, Lorenz WJ, 1993, "Functional Magnetic Resonance Imaging of Motoric Stimulation Measured at 1.5 Tesla." Z Med Phys 3, 88 - 91.
  • Schad LR, Trost U, Knopp MV, Müller E, Lorenz WJ, 1993, "Motor cortex stimulation measured by magnetic resonance imaging on a standard 1.5 T clinical scanner." Magn Reson Imaging 11, no. 4, 461 - 4.
  • Kauczor HU, Knopp MV, Branscheid D, Semmler W, 1993, "[Pulmonary sequestration: use of MR-angiography]." Aktuelle Radiol 3, no. 2, 120 - 2.
  • Schad LR, Semmler W, Knopp MV, Deimling M, Weinmann HJ, Lorenz WJ, 1993, "Preliminary evaluation: magnetic resonance of urography using a saturation inversion projection spin-echo sequence." Magn Reson Imaging 11, no. 3, 319 - 27.
  • Hoverath H, Kübler WK, Ostertag HJ, Doll J, Ziegler SI, Knopp MV, Lorenz WJ, 1993, "Scatter Correction in the Transaxial Slices of a Whole-Body Positron Emission Tomograph." Phys Med Biol 38, no. 6, 717 - 28.
  • Kauczor HU, Brix G, Dietl B, Jarosch K, Knopp MV, van Kaick G, 1993, "Bone marrow after autologous blood stem cell transplantation and total body irradiation: magnetic resonance and chemical shift imaging." Magn Reson Imaging 11, no. 7, 965 - 75.
  • Kauczor HU, Marin-Grez M, Gückel F, Knopp MV, 1993, "[Intraspinal cartilaginous exostosis as the cause of a Brown-Séquard syndrome]." Rofo 158, no. 1, 82 - 4.

1992

  • Knopp MV, Schönhofen H, Knopp A, 1992, "[A hepatic space-occupying lesion. Liver abscess due to a retained surgical towel]." Radiologe 32, no. 9, 451 - 2.
  • Delorme S, Knopp MV, Kauczor HU, Zuna I, Trost U, Haberkorn U, van Kaick G, 1992, "[Recurrence paralysis: computed tomographic analysis of intrathoracic findings]." Radiologe 32, no. 9, 430 - 5.
  • Gamroth AH, Schad LR, Wacker CM, Gehling U, Knopp MV, Betsch B, Clorius JH, van Kaick G, 1992, "[Measurement of the blood flow velocity in the pulmonary arteries using the magnetic resonance technique]." Radiologe 32, no. 4, 182 - 4.
  • Gehling U, Knopp M, Saggau W, Schulz V, 1992, "[Aortopulmonary fistula formation after operation of aortic isthmus stenosis as a rare cause of recurrent hemoptysis]." Pneumologie 46, no. 11, 587 - 90.
  • Schad LR, Gademann G, Knopp M, Zabel HJ, Schlegel W, Lorenz WJ, 1992, "Radiotherapy treatment planning of basal meningiomas: improved tumor localization by correlation of CT and MR imaging data." Radiother Oncol 25, no. 1, 56 - 62.
  • Kauczor HU, Knopp MV, Branscheid D, Semmler W, 1992, "Pulmonary sequestration: diagnosis based on MR angiographic findings." Am J Roentgenol 159, no. 2, 429 - 30.
  • Knopp MV, Bischoff H, Oberdorfer F, van Kaick G, 1992, "[Positron emission tomography of the thorax. The current clinical status]." Radiologe 32, no. 6, 290 - 5.

1991

  • Knopp MV, 1991, "PET complements CT in Imaging of Lung Tumors." Diagn Imaging 13, no. 10, 131 - 4.
  • Kauczor HU, Knopp MV, Delorme S, van Kaick G, 1991, "[Computed tomography of the upper mediastinum. Optimized contrast media application by the use of an infusion pump]." Rofo 155, no. 1, 46 - 52.

Unknown

  • Nguyen HT, Shah ZK, Mortazavi A, Pohar KS, Wei L, Jia G, Zynger DL, Knopp MV, "Non-invasive quantification of tumour heterogeneity in water diffusivity to differentiate malignant from benign tissues of urinary bladder: a phase I study." Eur Radiol
  • Yang X, Miller MJ, Friel HT, Slijepcevic A,Knopp MV, "Perforator Phase Contrast Angiography of Deep Inferior Epigastric Perforators: A Better Preoperative Imaging Tool for Flap Surgery than Computed Tomographic Angiography?." Invest Radiol
  • Wei W, Lambach B, Jia G, Flanigan D, Chaudhari AM, Wei L, Rogers A, Payne J, Siston RA, Knopp MV, "Assessing the Effect of Football Play on Knee Articular Cartilage Using Delayed Gadolinium-Enhanced MRI of Cartilage (dGEMRIC)." Magn Reson Imaging

Presentations

  • "Plenary Lectures." 2003, Presented at Third International Congress on MR Mammography, Jena, DE|DEU
  • "Contrast Agents." 2003, Presented at MR Angio Club 2003, Dublin, IE|IRL
  • "Plenary Lecture: How to integrate MR mammography into a dedicated women's health service?." 2003, Presented at Third International Congress on MR Mammography, Jena, DE|DEU
  • "Plenary Lecture: Contrast agents for MR mammography: current status and on-going developments." 2003, Presented at Third International Congress on MR Mammography, Jena, DE|DEU
  • "Contrast Agents: Overview." 2003, Presented at MR Angio Club 2003, Dublin, IE|IRL
  • "How functional/quantitative imaging and therapy response monitoring are enabling breakthroughs in care." 2011, Presented at Philips Champions in Radiology, Hollywood,
  • "Regulatory issues related to the introduction of new MRI agents." 2002, Presented at ISMRM MR of Cancer Study Group Workshop, Santa Cruz,
  • "John K. Lattimer Lecture: Dynamic Contrast-Enhanced MRI." 2004, Presented at American Urological Association (AUA) 2004 Annual Meeting, San Francisco,
  • "Current Concepts in MR Based Therapy Assessment." 2004, Presented at ISMRM 12th Scientific Meeting, Kyoto, JP|JPN
  • "Imaging - Its present and future for cancer diagnosis and clinical trials." 2005, Presented at AACR Inaugural Scientist-Survivor Program Educational Workshop, Bethesda,
  • ""Sites": Introduction, Context & Orientation." 2005, Presented at Philips 7T User Meeting, Cleveland,
  • "Scientific Program 2: High Field MRI and MRS." 2007, Presented at Philips 7T User Meeting, Nashville,
  • "Dose-Response, DCE-MRI and Safety of Gd-chelates at 7T." 2007, Presented at Philips 7T User Meeting, Nashville,
  • "Refresher Course: MR and CT Techniques in the Evaluation of Tumor Angiogenesis." 2002, Presented at Radiological Society of North America 2002 Annual Meeting, Chicago,
  • "Clinical Challenges and Related Software/Informatics Requirements." 2004, Presented at Joint BECON/BISTIC Symposium 2004: Biomedical Informatics for Clinical Decision Support: A Vision for the 21st Century, Bethesda,
  • "Image-Based Clinical Trials: Requirements and Solutions - An Investigator's Perspective." 2004, Presented at CBI's 2nd Annual Medical Imaging for Clinical Trials, Philadelphia,
  • "Plenary Session: Early Predictors of Tumor Response, Questions and Panel Discussion." 2005, Presented at Radiological Society of North America 2005 Annual Meeting, Chicago,
  • "Imaging Needs in Renally Impaired Patients." 2007, Presented at American Society of Nephrology Annual Meeting, San Francisco,
  • "Gastrointestinal (CT/MR Perfusion: Liver)." 2007, Presented at Radiological Society of North America 2007 Annual Meeting, Chicago,
  • "Future: Contrast agents - what is new?." 2009, Presented at Fifth International Congress on MR-Mammography, Jena, DE|DEU
  • "Challenges for Multi-Modality Mammography in large Medical Centers." 2009, Presented at Fifth International Congress on MR-Mammography,
  • "The Third Frontier's Worldwide Reach." 2009, Presented at 2009 BioOhio Annual Conference, Columbus,
  • "Plenary Keynote: Clinical Opportunities and Challenges for Cancer Imaging with Nanoparticles." 2010, Presented at 2010 WMIC Post-Congress Symposium, Taipei,
  • "Novel Probes for Cancer Detection." 2010, Presented at 2010 World Molecular Imaging Congress, Kyoto, JP|JPN
  • "MR in Clinical Routine Assessment of Cancer Treatment." 2010, Presented at ISMRM MR of Cancer Study Group Workshop, Santa Cruz,
  • "How do we accelerate clinical utilization of 7T: Opportunities & Challenges." 2010, Presented at Philips 7T User Meeting 2010, Noordwijk,
  • "Clinical MRI: How do we move beyond the visual interpretation? - Strategies & Challenges." 2010, Presented at ISMRM MR of Cancer Study Group Workshop, Santa Cruz,
  • "CTSA Imaging Working Group Meeting: How to Get Clinical Trial Studies Read by Radiologists: Models and Reimbursements." 2010, Presented at Radiological Society of North America 2010 Annual Meeting, Chicago,
  • "Applications of FDG/FLT PET for Targeted Therapies in Early Clinical Development." 2011, Presented at 112th American Society of Clinical Pharmacology & Therapeutics (ASCPT) Annual Meeting, Dallas,
  • "Refresher Course: MR and CT Techniques in the Evaluation of Tumor Angiogenesis." 2001, Presented at Radiological Society of North America 2001 Annual Meeting, Chicago,
  • "CNS MR Perfusion Imaging: What is it Today and What Can it be Tomorrow?." 2002, Presented at ASNR 40th Annual Meeting, Vancouver, CA|CAN
  • "Clinical Categorical Course: Current Clinical State of the Art: Dynamic Imaging for Functional Assessment." 2002, Presented at ISMRM 10th Scientific Meeting, Honolulu,
  • "Clinical Categorical Course: Current Clinical State of the Art." 2002, Presented at ISMRM 10th Scientific Meeting, Honolulu,
  • "Advanced MRA Techniques: Higher SNR Methods: MRA Contrast Agents." 2002, Presented at ISMRM 10th Scientific Meeting, Honolulu,
  • "Plenary Lectures: Monitoring Treatment Response." 2007, Presented at ISMRM 15th Annual Meeting, Berlin, DE|DEU
  • "Special Symposium: Magnetic Resonance in Clinical Trials." 2007, Presented at ISMRM 15th Annual Meeting, Berlin, DE|DEU
  • "Categorial Course: Cardiovascular MRI: From Principles to Protocols: Current and Novel Contrast Agents for MRA." 2007, Presented at ISMRM 15th Annual Meeting,
  • "Translational Research in Bio-Imaging." 2007, Presented at IBGP-792: Introduction to Translational Biomedical Research, Columbus,
  • "Biomedical Imaging: Insight, Imagination and Innovation." 2011, Presented at Advances in Veterinary Medicine Research Week, Columbus,
  • "Scientific Session: Monitoring Therapy." 2011, Presented at 2011 World Molecular Imaging Congress, San Diego,
  • "RSNA/ACRIN Imaging Researchers Workshop: Informatics Tools in Support of Clinical and Translational Research: Integration of the Imaging Informatics Infrastructure within the Clinical and Translational Research Enterprise." 2011, Presented at ACRIN Annual Meeting, Arlington,
  • "RSNA/ACRIN Imaging Researchers Workshop: Informatics Tools in Support of Clinical and Translational Research: Imaging Core Lab Workflow Management." 2011, Presented at ACRIN Annual Meeting, Arlington,
  • "RSNA/ACRIN Imaging Researchers Workshop: Caveats and Pitfalls in Implementing an Imaging Core to Support Clinical and Translational Research: Funds Flow for Imaging Clinical Overreads and Research Data Extraction in Clinical Trials (Charging and Distribution)." 2011, Presented at ACRIN Annual Meeting, Arlington,
  • "Biomedical Imaging: Insight, Imagination and Innovation." 2011, Presented at BME 581/881 Seminar Series, Columbus,
  • "Applied image processing for characterization of disease and response assessment in clinical oncology." 2006, Presented at 9th Medical Image Computing and Computer Assisted Intervention (MICCAI) Conference, Copenhagen, DK|DNK
  • "Current Trends in MRI." 2007, Presented at 3rd Annual Magnetic Resonance Imaging Seminar, Columbus,
  • "caBIG Imaging Workspace and Cooperative Clinical Research Session." 2007, Presented at caBIG Imaging Workspace and Cooperative Clinical Research Session, Washington,
  • "Plenary Speaker: Biomedical Research and Agricultural Research." 2010, Presented at The Ohio State University College of Veterinary Medicine Focus-Forward Weekend, Columbus,
  • "Advancing Cancer Research Through Imaging: Operational Strategies to Integrate Imaging Effectively into Clinical Cancer Research and Opportunities for Cancer Center Collaborations." 2010, Presented at 2010 AACI/CCAF Annual Meeting, Chicago,
  • "Introducing High Field MRI and Novel Imaging Protocols into Oncology Clinical Trials." 2011, Presented at UC Denver C-TRIC Lecture, Denver,
  • "Contrast Agents for Coronary MRA: Overview of MR Contrast Agents for Cardiac Applications." 2000, Presented at First International Workshop on Coronary MR and CT Angiography, Lyon, FR|FRA
  • "Sumamry/Recommendations." 2001, Presented at Higher Field (1.5T & Up) in Oncology: Strategic Frontiers in Cancer Diagnosis and Treatment, Glasgow,
  • "Special Symposium: Magnetic Resonance in Clinical Trials: Rountable Discussion - Current Challenges and Possible Solutions." 2007, Presented at ISMRM 15th Annual Meeting, Berlin, DE|DEU
  • "Sophisticated OSUMC Entrepreneurs." 2008, Presented at From Concept to Commercialization: Maximizing the Potential of Translational Research, Columbus,
  • "Refresher Course: Update Course in Diagnostic Radiology Physics: Imaging Technologies in Oncology - Introduction: Imaging for Treatment Evaluation." 2008, Presented at Radiological Society of North America 2008 Annual Meeting, Chicago,
  • "DWI, MRS and beyond." 2009, Presented at Fifth International Congress on MR-Mammography, Jena, DE|DEU
  • "Breast MR Masterclass - Overview of Breast MRI." 2010, Presented at 2010 SMRT Annual Meeting, Stockholm, SE|SWE
  • "Tumor Vascular Imaging: From Bedside and Back Again." 2002, Presented at NIH CCR Grand Rounds, Bethesda,
  • "Update on MR Contrast Agent Safety with Special Focus on NSF/NFD." 2007, Presented at The Ohio State University Medical Center, Columbus,
  • "Opportunities and Requirements for CALGB in regard to caBIG In Vivo Imaging Workspace." 2007, Presented at caBIG In Vivo Imaging Workspace Face-to-Face Meeting, Bethesda,
  • "Imaging Research and Facilities in Radiology." 2008, Presented at Davis Heart and Lung Research Institute Imaging Symposium, Columbus,
  • "Imaging and Targeted Therapy: Round Table Discussion." 2008, Presented at International Thoracic Oncology Congress Dresden, Dresden, DE|DEU
  • "Imaging and Targeted Therapy: Imaging Trials in Thoracic Oncology." 2008, Presented at International Thoracic Oncology Congress Dresden, Dresden, DE|DEU
  • "Cancer Center Investments in New Science: Biomarkers, Imaging and Tissue Banks." 2008, Presented at Association of American Cancer Institutes 2008 Annual Meeting, Chicago,
  • "Breast Imaging." 2010, Presented at San Antonio Breast Cancer Conference Review, Columbus,
  • "Pushing the Limits: The Contrast Agents." 2008, Presented at Visions for the Future of MRI, Berlin, DE|DEU
  • "The Use of intravenous contrast in MRI." 2009, Presented at ISMRM 17th Scientific Meeting, Honolulu,
  • "Methods Workshop: Integrating Molecular Imaging with Biomarkers and Functional Measures." 2009, Presented at American Association for Cancer Research 100th Annual Meeting, Denver,
  • "Forum: Assessing Response Using Imaging to Determine Endpoints in Clinical Trials." 2009, Presented at American Association for Cancer Research 100th Annual Meeting, Denver,
  • "Refresher Course: Update Course in Diagnostic Radiology Physics: Imaging Technologies in Oncology - Introduction. Imaging for Treatment Evaluation.." 2009, Presented at Radiological Society of North America 2009 Annual Meeting, Chicago,
  • "Weekday Educational Course: MR Physics & Techniques for Clinicians: Contrast Agents." 2011, Presented at ISMRM 19th Scientific Meeting, Montreal, CA|CAN
  • "Weekday Educational Course: Clinical Applications of Ultra-high Field 7T MR - Moving to FDA/EU Approval: Potential Clinical Applications for Ultra-High Field MRI." 2011, Presented at ISMRM 19th Scientific Meeting, Montreal, CA|CAN
  • "Vendor Presentation Forum: Advances in Contrast Enhanced MRI." 2002, Presented at Clinical Magnetic Resonance Society 2002 Annual Meeting, Lake Buena Vista,
  • "MRI in Therapy Monitoring." 2002, Presented at Clinical Magnetic Resonance Society 2002 Annual Meeting, Lake Buena Vista,
  • "MRI in Oncology." 2002, Presented at Clinical Magnetic Resonance Society 2002 Annual Meeting, Lake Buena Vista,
  • "MR Angiography - Technqiues, Tips and Protocols." 2002, Presented at Clinical Magnetic Resonance Society 2002 Annual Meeting, Lake Buena Vista,
  • "High Field MR >=3T, Current Status and Trends." 2002, Presented at Clinical Magnetic Resonance Society 2002 Annual Meeting, Lake Buena Vista,
  • "Refresher Course: MR and CT Techniques in the Evaluation of Tumor Angiogenesis." 2003, Presented at Radiological Society of North America 2003 Annual Meeting, Chicago,
  • "Molecular Imaging." 2001, Presented at Breast Cancer Think Tank Retreat 2001, Chantilly,
  • "The Role of Nuclear Medicine in Treatment Monitoring and Treatment Planning: The Complementary Role of PET and MRI." 2002, Presented at SNM 2002 Mid-Winter Educational Symposium, Scottsdale,
  • "Symposium on Pulmonary Embolism: Current Status of MRI in Pulmonary Imaging." 2002, Presented at 29th Annual Meeting and Scientific Sessions of the American College of Nuclear Medicine, Scottsdale,
  • "Summary." 2002, Presented at Third National Forum on Biomedical Imaging in Oncology, Arlington,
  • "Devices: Addressing the Challenges." 2002, Presented at Third National Forum on Biomedical Imaging in Oncology, Arlington,
  • "Scientific Session 2: General 1." 2009, Presented at Philips 7T User Meeting 2009, Dallas,
  • "How to Make 7T Reimbursable: Issues for Patient Care and Clinical Trials." 2009, Presented at Philips 7T User Meeting 2009, Dallas,
  • "Vascular MR Imaging: Facts & Challenges: Introduction: MR Contrast Agents: Capabilities and Choices." 2002, Presented at ISMRM 10th Scientific Meeting - Bracco Forum, Honolulu,
  • "Vascular MR Imaging: Facts & Challenges." 2002, Presented at ISMRM 10th Scientific Meeting - Bracco Forum, Honolulu,
  • "Female Breast: Therapy-monitoring: Dynamic monitoring of anti-angiogenesis therapy for breast cancer." 2003, Presented at MR 2003 Garmisch: 10th International MRI Symposium, Garmisch, DE|DEU
  • "Opportunities in MR: Strategic Perspectives." 2007, Presented at Bayer Schering Pharma Diagnostic Imaging Workshop, New York,
  • "Innovative Imaging Modalities." 2007, Presented at Thoracic CME Symposium, Columbus,
  • "Imaging as a Biomarker to Assess Therapeutic Response: Where are we and where do we need to go?." 2007, Presented at Grand Rounds Speaker at Beth Israel Deaconess Medical Center, Boston,
  • "Clinical Categorical Course: Cancer Imaging." 2005, Presented at ISMRM 13th Scientific Meeting, Miami Beach,
  • "Breast Imaging: Dynamic Contrast-Enhanced Techniques and Computer-Aided Diagnosis for Breast MRI." 2005, Presented at ISMRM 13th Scientific Meeting, Miami Beach,
  • "Advanced Neuro MR: Brain MRI: Microcirculation/Angiogenesis." 2005, Presented at ISMRM 13th Scientific Meeting, Miami Beach,
  • "How do contrast agents reflect pathology?." 2006, Presented at 4th International Congress on MR Mammography, Jena, DE|DEU
  • "Contrast agents for MR-Mammography: upcoming applications." 2006, Presented at 4th International Congress on MR Mammography, Jena, DE|DEU
  • "Panel I: Molecular and Clinical Oncology Perspective - High Field MR: A Molecular Biology Perspective." 2001, Presented at Higher Field (1.5T & Up) in Oncology: Strategic Frontiers in Cancer Diagnosis and Treatment, Glasgow,
  • "Panel I: Molecular and Clinical Oncology Perspective." 2001, Presented at Higher Field (1.5T & Up) in Oncology: Strategic Frontiers in Cancer Diagnosis and Treatment, Glasgow,
  • "Intraindividual Comparison of Contrast Enhancement in Brain Tumors: A Blinded Reader Comparison of a Standard Gd-chelate (Gd-DTPA) vs. a Weak Interacting (Gd-BOPTA)." 2001, Presented at ASNR 39th Annual Meeting, Boston,
  • "3D MR Colonography after Exclusive Intravenous Administration of a Hepatobiliary Contrast Agent." 2001, Presented at ASNR 39th Annual Meeting, Boston,
  • "Guidelines and Recommendations." 2005, Presented at Berlex Multidisciplinary Advisory Board, Phoenix,
  • "Clinical and Economic Relevance." 2005, Presented at Berlex Multidisciplinary Advisory Board, Phoenix,
  • "Plenary Lectures: Clinical Trials." 2006, Presented at ISMRM 14th Annual Meeting, Seattle,
  • "MRI of the CNS: Future Perspectives for Contrast Enhancement in MRI." 2001, Presented at UK Radiological Congress 2001, London,
  • "Intraindividual Comparison of Different MR Contrast Agents for Multiphasic MR Angiography." 2001, Presented at Radiological Society of North America 2001 Annual Meeting, Chicago,
  • "Special Symposium: Grant Writing: Opportunities, Needs and Strategies." 2006, Presented at ISMRM 14th Annual Meeting, Seattle,
  • "Perspectives on high field and ultra-high field imaging." 2006, Presented at Philips Gold Corporate Member Lunchtime Symposia at ISMRM 14th Annual Meeting, Seattle,
  • "Clinical Categorical Course: Therapy Assessment." 2006, Presented at ISMRM 14th Annual Meeting, Seattle,
  • "Dynamic contrast enhanced MR as an assessment tool of therapeutic response in oncological therapies." 2006, Presented at American Association of Pharmaceutical Scientists (AAPS) Annual Meeting, San Antonio,
  • "MRI Contrast Agents." 2008, Presented at 891.01 CESBMI (Comprehensive Engineering & Science of Biomedical Images) Seminar, Columbus,
  • "Micro-imaging: a link from in vivo to tissue." 2009, Presented at 891.01 CESBMI (Comprehensive Engineering & Science of Biomedical Images) Seminar, Columbus,
  • "Whole Body Imaging: Opportunities and Challenges." 2010, Presented at 891.01 CESBMI (Comprehensive Engineering & Science of Biomedical Images) Seminar, Columbus,
  • "PET/CT: Capabilities and Expectations on Design, Quality and Performance - Today and in 5 Years." 2012, Presented at Philips PET/CT Seminar, Columbus,
  • "PET/MRI – Bringing a new imaging modality into clinical practice." 2012, Presented at 891.01 Comprehensive Engineering and Science of Biomedical Images (CESBMI) Seminar Series, Columbus,
  • "Biomedical Imaging: Visualizing Anatomy, Physiology and Pathophysiology in Vivo." 2010, Presented at Mechanical Engineering 888 Seminar Series, Columbus,
  • "Clinical Trials in Radiology: from the concept to the peer review paper." 2010, Presented at 891.01 CESBMI (Comprehensive Engineering & Science of Biomedical Images) Seminar, Columbus,
  • "Biomedical Imaging: Insight, Imagination and Innovation." 2012, Presented at Biophysics Seminar Series, Columbus,
  • "Monitoring Oncologic Therapies: Current Concepts and Best Practices." 2012, Presented at University of Texas Medical Branch Cooley Visiting Professor Lecture, Galveston,
  • "Imaging tumor perfusion in clinical trials." 2012, Presented at Annual International Thyroid Oncology (ITOG) 2012 Meeting, Columbus,
  • "Imaging in Medicine: Innovation, Insight and Imagination." 2012, Presented at National Student Research Forum, Galveston,
  • "Concepts and Opportunities in Perioperative Imaging." 2012, Presented at University of Texas Medical Branch Residents Clinical Research Review, Galveston,
  • "DCE MRI in oncology standardization & validation issues." 2012, Presented at ISMRM 20th Annual Meeting, Melbourne, AU|AUS
  • "Contrast Agents." 2012, Presented at ISMRM 20th Annual Meeting, Melbourne, AU|AUS
  • "Imaging in Medicine: Innovation, Insight and Imagination." 2012, Presented at ENGR 4891 Seminar,
  • "Imaging approaches relevant for Regenerative Medicine and Cell-Based Therapies." 2012, Presented at Center for Regenerative Medicine and Cell Based Therapies (CRMCBT) 1st Annual Retreat,
  • "Imaging." 2012, Presented at Center for Regenerative Medicine and Cell Based Therapies (CRMCBT) 1st Annual Retreat,
  • "High Tesla MR Imaging." 2012, Presented at 2012 Congress of Neurological Surgeons Annual Meeting, Chicago,
  • "Imaging as a biomarker." 2012, Presented at ECOG-ACRIN Imaging Investigator Workshop, Pentagon City,
  • "IROC Model." 2012, Presented at ECOG-ACRIN Imaging Investigator Workshop, Pentagon City,
  • "The Alliance." 2012, Presented at ECOG-ACRIN Imaging Investigator Workshop, Pentagon City,
  • "Advanced imaging for cartilage: How can we evaluate cartilage better to determine." 2012, Presented at OSU Sports Medicine Cartilage Symposium 2012, Columbus, US|USA
  • "Virtual Communication for Managing Clinical Trials." 2013, Presented at 2013 RTOG Semiannual Meeting, San Diego,
  • "Introduction to biomedical imaging and visualization." 2013, Presented at Mathematical Challenges in Biomolecular/Biomedical Imaging and Visualization, Columbus,
  • "Imaging in Medicine: Innovation, Insight and Imagination." 2013, Presented at ENGR 4891 Seminar,
  • "Contrast agent clinical applications." 2013, Presented at Radiology 8814 MRI Course, Columbus,
  • "Current Concepts in Oncologic Imaging and Update on Capabilities at OSU." 2013, Presented at OSU College of Veterinary Medicine Comparative Oncology Signature Program Meeting, Columbus,
  • "Contrast Agents." 2013, Presented at ISMRM 21st Annual Meeting, Salt Lake City,
  • "The IROC Grant and the Integrated Imaging Core Lab effort." 2013, Presented at ECOG-ACRIN May Meeting, Atlanta,
  • "Imaging Pharmaceuticals 2013: What do I need to know as a Radiologist?." 2013, Presented at Noon Conference, Columbus,
  • "Advanced Neuroimaging: Frontiers and Capabilities for Clinical Application." 2013, Presented at 2013 American College of Veterinary Internal Medicine Forum, Seattle,
  • "Clinical Potential of Molecular Imaging in Veterinary Medicine." 2013, Presented at 2013 American College of Veterinary Internal Medicine Forum, Seattle,
  • "The Relationship Between Radiology and Molecular Imaging." 2013, Presented at 2013 World Molecular Imaging Congress, Savannah, US|USA
  • "Clinical Applications of Quantitative DCE-MRI." 2013, Presented at Radiological Society of North America 2013 Annual Meeting, Chicago,
  • "Current State of the Art in Neuroimaging with special focus on PET." 2013, Presented at OSU Neurology & Neurosurgery Grand Rounds, Columbus,
  • "Visions for Digital PET/CT." 2013, Presented at Philips Healthcare AMI Advisory Board, Cleveland,
  • "How can UHF MRI become a specialty Neuroimaging Clinical Exam?." 2013, Presented at 9th Biennial 2013 Minnesota Workshop on High and Ultra-High Field Imaging, Minneapolis,
  • "Visions for Digital PET/CT." 2013, Presented at Philips Healthcare AMI Advisory Board, Lyon, FR|FRA
  • "TBD." 2014, Presented at Visiting Professor for Radiology Residents Conference, Baltimore,
  • "Innovation in Clinical Radiology: Stagnation, Evolution or Revolution." 2014, Presented at Visiting Professor for Radiology Grand Rounds, Baltimore,
  • "From Imagination to Imaging: Tools for Regenerative Medicine." 2014, Presented at Center for Regenerative Medicine and Cell-based Therapies Scientific Retreat TED Talks, Columbus,
  • "Evolution of MRI and the Latest in MR Imaging." 2014, Presented at 10th Annual OSU Wexner Medical Center MRI Conference, Columbus,
  • "The future of collaboration between diagnostic imaging and radiation oncology in research." 2014, Presented at AAPM ORVC Spring Clinical Symposium,
  • "Advanced Neuroimaging Efforts at OSU." 2014, Presented at CNS Retreat,
  • "Vereos Digital PET/CT: A technology innovation that can redefine our vision for PET/CT." 2014, Presented at The Future of PET - Philips User Event at EANM 2014, Gothenburg, SE|SWE
  • "Vereos Digital PET/CT: A technology innovation that can redefine our vision for PET/CT." 2014, Presented at Philips PET User Group Meeting, Tours, FR|FRA
  • "Clinical Applications of Quantitative DCE-MRI." 2014, Presented at 2014 RSNA Annual Meeting, Chicago,
  • "Leaping Molecular Imaging Forward." 2014, Presented at Philips Key Opinion Leaders Event, Columbus,
  • "Designing Clinical Research in Radiology - Part 1." 2014, Presented at Dept. of Radiology Noon Conference,
  • "Designing Clinical Research in Radiology - Part 2." 2014, Presented at Dept. of Radiology Noon Conference,
  • "The Imaging and Radiation Oncology Core (IROC) Effort for the NCI National Clinical Trial Network (NCTN)." 2014, Presented at Dept. of Radiology Noon Conference,
  • "Initial Clinical Experience using a Digital Solid State PET Detector PET/CT System for Oncologic Whole Body Imaging." 2015, Presented at ACNM Annual Meeting 2015, San Antonio,
  • "Relevant regulatory compliance aspects in molecular imaging research." 2015, Presented at Dept. of Radiology Noon Conference,
  • "Quo Vadis Postprocessing." 2015, Presented at Philips ICAP Software Engineers Retreat, Eindhoven, NL|NLD
  • "Initial experience with the solid state digital photon counting chip." 2015, Presented at Philips Corporate Research, Aachen, DE|DEU
  • "Advanced Concepts in GU Oncologic Imaging." 2015, Presented at Genitourinary Oncology Grand Rounds,
  • "Redefining the clinical PET/CT acquisition by re-optimization of its components." 2015, Presented at 45th Annual Scientific Meeting of the Australian and New Zealand Society of Nuclear Medicine, Brisbane, AU|AUS
  • "Low dose PET Imaging for nutrition and metabolism studies." 2015, Presented at 45th Annual Scientific Meeting of the Australian and New Zealand Society of Nuclear Medicine, Brisbane, AU|AUS
  • "Update on Digital PET/CT Research and Building Blocks of a R Series NIH Grant Based on a Recently Submitted Grant." 2015, Presented at Dept. of Radiology Noon Conference,
  • "Molecular Imaging, Radiomics and Imaging Genomics." 2015, Presented at 5th Annual Meeting of the Society for Translational Oncology, Columbus,
  • "Insight." 2015, Presented at 45th Annual Scientific Meeting of the Australian and New Zealand Society of Nuclear Medicine, Brisbane, AU|AUS
  • "Bringing a next generation technology into global healthcare: a vision, innovation and you." 2015, Presented at Philips Healthcare Town Hall Meeting,
  • "Redefining the clinical PET/CT acquisition by re-optimization of its components and first experience using a digital detector PET/CT." 2015, Presented at Australian and New Zealand Society of Nuclear Medicine New Zealand Branch Guest Speaker Presentations, Aukland, NZ|NZL
  • "Molecular Imaging to assess and monitor tissue proliferation by 18F-FLT PET/CT during investigational Breast Cancer Therapy." 2015, Presented at WMIC 2015, Honolulu,
  • "Technical and clinical innovations in PET." 2015, Presented at Philips Advanced Molecular Imaging Global User Event, Berlin, DE|DEU
  • "First Experiences with Vereos Digital PET/CT." 2015, Presented at Philips Event at British Nuclear Medicine Society Spring Meeting 2015, Brighton, GB|GBR
  • "Cancer Imaging Research: Framing the Future." 2015, Presented at ECOG-ACRING Spring 2015 Group Meeting, Chicago,
  • "What is needed to bring 7T to the clinic? What’s needed for neuro?." 2015, Presented at ISMRM 2015, Toronto, CA|CAN
  • "Digital Photon Counting: Initial Clinical Experience with the Next Generation PET/CT." 2015, Presented at SNMMI 2015, Baltimore,
  • "Overview of PET-CT and Other Functional Imaging in Oncology." 2015, Presented at NRG Oncology Seminannual Meeting, Denver,
  • "Cost/workload issues for radiology departments." 2015, Presented at National Biomarker Development Alliance (NBDA) Convergence Conference III: Standards for Biomarker Measurement using Diffusion Weighted MRI, Scottsdale,
  • "Central lab QA." 2015, Presented at National Biomarker Development Alliance (NBDA) Convergence Conference III: Standards for Biomarker Measurement using Diffusion Weighted MRI, Scottsdale,
  • "Managers of Molecular Imaging Laboratories Symposium at WMIC." 2015, Presented at WMIC 2015, Honolulu,
  • "Phase I Trial comparing a Digital Detector PET/CT System with current photomultiplier PET Technology in Diagnostic Oncology." 2015, Presented at EANM 2015, Hamburg, DE|DEU
  • "Clinical experience with high resolution 2 mm PET reconstructions: Ingenuity TF PET/CT and Vereos." 2015, Presented at Philips Advanced Molecular Imaging Global User Event, Berlin, DE|DEU
  • "Clinical Experience with Vereos Digital Photon Counting PET/CT system - a year in review." 2016, Presented at 32nd International Austrian Winter Symposium, Zell am See, AT|AUT
  • "The Role of Industrial and Academic Partnership (MOMIL)." 2016, Presented at 2016 World Molecular Imaging Congress, New York,
  • "Positron Emission Tomography." 2016, Presented at CARS 2016, Heidelberg, DE|DEU
  • "What you need to know to publish Imaging Research." 2015, Presented at Dept. of Radiology Noon Conference,

Papers in Proceedings

  • Binzel KM, Zhang J, Hall N, Ramaswamy B, Knopp MV "Decreasing radiation dose and acquisition time in F-18-FLT PET/CT." in OSUWMC Research Day 2012.
  • Patents

    • Bjoernerud A, Briley-Saebo K, Knopp MV, McGill S, Schoenberg SO. "Method of Magnetic Resonance Imaging." Patent number: WO0072037
    • Knopp MV, Giesel F, von Tengg-Kobligk H, Radeleff J. "[Imaging of the Colon Using Contrast Agents]." Patent number: ITMI20000193
    • Schoenberg SO, Bock M, Knopp MV, Laub G. "Method for Separating Arteries and Veins in 3D MR Angiographic Images Using Correlation Analysis." Patent number: US6,377,835
    • Knopp MV, Giesel F, von Tengg-Kobligk H, Radeleff J. "Use of Contrast Agents in the Manufacture of Diagnostic Agent for the Visualisation of the Intestinal Lumen." Patent number: PT1251875T